Omnicomm Systems (OMCM) 10-Q 14 Aug 15 2015 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 13, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	OMNICOMM SYSTEMS INC
Trading Symbol	OMCM
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		92,845,102
Amendment Flag	false
Entity Central Index Key	1,034,592
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2

Condended Consolidated Balance

Condended Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash	$ 1,186,088	$ 522,914
Accounts receivable, net of allowance for doubtful accounts of $99,083 and $186,085, respectively	3,003,338	3,416,151
Prepaid expenses	164,585	228,082
Prepaid stock compensation, current portion	219,275	153,500
Other current assets	12,647	18,305
Total current assets	4,585,933	4,338,952
Property and equipment, net	654,337	468,136
Other assets
Intangible assets, net	171,853	203,921
Goodwill	549,193	596,620
Prepaid stock compensation	235,215	146,653
Other assets	47,870	49,092
TOTAL ASSETS	6,244,401	5,803,374
CURRENT LIABILITIES
Accounts payable and accrued expenses	2,124,190	1,894,185
Deferred revenue, current portion	6,696,830	5,840,875
Line of credit	0	4,000,000
Convertible notes payable, current portion, net of discount of $-0- and $-0-, respectively	75,000	75,000
Patent settlement liability, current portion	962,500	962,500
LONG TERM LIABILITIES
Line of credit, long term	5,000,000	0
Notes payable, related parties, long term, net of current portion, net of discount of $1,106,070 and $568,209, respectively	5,832,930	5,700,791
Notes payable, long term, net of current portion	792,500	812,500
Deferred revenue, long term, net of current portion	1,867,099	2,393,068
Convertible notes payable, related parties, long term, net of current portion	8,810,000	8,815,000
Convertible notes payable, long term, net of current portion	775,000	775,000
Patent settlement liability, long term, net of current portion	509,648	669,825
TOTAL LIABILITIES	$ 39,880,489	$ 41,578,206
COMMITMENTS AND CONTINGENCIES (See Note 11)
SHAREHOLDERS' (DEFICIT)
Preferred stock	$ 0	$ 0
Common stock, 250,000,000 shares authorized, 92,845,102 and 91,561,802 issued and outstanding, respectively, at $0.001 par value	92,846	91,562
Additional paid in capital - preferred	4,717,804	4,717,804
Additional paid in capital - common	37,931,778	37,634,555
Accumulated other comprehensive (loss)	(327,358)	(243,827)
Accumulated deficit	(76,055,533)	(77,979,301)
TOTAL SHAREHOLDERS' (DEFICIT)	(33,636,088)	(35,774,832)
TOTAL LIABILITIES AND SHAREHOLDERS' (DEFICIT)	6,244,401	5,803,374
Series B Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series C Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	0	0
Series A Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	4,125	4,125
Series D Preferred Stock [Member]
SHAREHOLDERS' (DEFICIT)
Preferred stock	250	250
Conversion Feature Liability, Related Parties [Member]
CURRENT LIABILITIES
Derivative liabilities, current	1,757,681	2,729,902
Conversion Feature Liability [Member]
CURRENT LIABILITIES
Derivative liabilities, current	196,474	214,500
Warrant Liability, Related Parties [Member]
CURRENT LIABILITIES
Derivative liabilities, current	4,292,816	6,496,448
Warrant Liability [Member]
CURRENT LIABILITIES
Derivative liabilities, current	187,821	198,612
Total current liabilities	$ 16,293,312	$ 22,412,022

Condended Consolidated Balance3

Condended Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Allowance for doubtful accounts (in Dollars)	$ 99,083	$ 186,085
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares undesignated (in Dollars)	$ 3,772,500	$ 3,772,500
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	92,845,102	91,561,802
Common stock, shares outstanding	92,845,102	91,561,802
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Series B Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	230,000	230,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, liquidation preference (in Dollars)	$ 0	$ 0
Series C Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	747,500	747,500
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, liquidation preference (in Dollars)	$ 0	$ 0
Series A Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	4,125,224	4,125,224
Preferred stock, shares outstanding	4,125,224	4,125,224
Preferred stock, liquidation preference (in Dollars)	$ 4,125,224	$ 4,125,224
Series D Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	250,000	250,000
Preferred stock, shares issued	250,000	250,000
Preferred stock, shares outstanding	250,000	250,000
Notes Payable, Other Payables [Member]
Notes payable discount (in Dollars)	$ 1,106,070	$ 568,209
Convertible Notes Payable [Member]
Notes payable discount (in Dollars)	$ 0	$ 0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenues	$ 4,788,160	$ 3,465,491	$ 9,175,614	$ 6,611,538
Reimbursable revenues	46,739	143,258	497,412	179,486
Total revenues	4,834,899	3,608,749	9,673,026	6,791,024
Cost of goods sold	1,009,580	813,076	1,969,075	1,567,159
Reimbursable expenses-cost of goods sold	40,368	154,699	432,470	263,891
Gross margin	3,784,951	2,640,974	7,271,481	4,959,974
Operating expenses
Salaries, benefits and related taxes	2,764,113	2,538,236	5,542,217	5,228,311
Rent and occupancy expenses	227,480	219,403	482,711	443,987
Consulting services	81,311	30,111	176,740	50,558
Legal and professional fees	98,592	114,940	218,128	199,897
Travel	184,723	202,466	471,670	417,360
Telephone and internet	52,576	46,905	83,955	90,491
Selling, general and administrative	467,786	333,140	827,607	592,972
Bad debt expense	14,972	55,648	(5,402)	76,002
Depreciation expense	56,343	60,023	108,505	122,433
Amortization expense	10,057	11,610	20,237	23,227
Total operating expenses	3,957,953	3,612,482	7,926,368	7,245,238
Operating (loss)	(173,002)	(971,508)	(654,887)	(2,285,264)
Other income/(expense)
Interest expense, related parties	(672,649)	(573,558)	(1,299,785)	(1,240,176)
Interest expense	(73,161)	(55,387)	(145,897)	(106,732)
Interest income	0	18	0	65
Change in derivative liabilities	5,590,517	2,257,688	4,072,798	2,802,571
Transaction gain/(loss)	7,248	(8,883)	(48,076)	(13,319)
Income/(loss) before income taxes	4,678,953	648,370	1,924,153	(842,855)
Income taxes (expense)	0	(16,306)	(385)	(33,961)
Net income/(loss)	4,678,953	632,064	1,923,768	(876,816)
Preferred stock dividends in arrears
Series A preferred	(51,424)	(51,424)	(102,283)	(102,283)
Total preferred stock dividends	(51,424)	(51,424)	(102,283)	(102,283)
Net income/(loss) attributable to common stockholders	$ 4,627,529	$ 580,640	$ 1,821,485	$ (979,099)
Net income/(loss) per share
Basic (in Dollars per share)	$ 0.05	$ 0.01	$ 0.02	$ (0.01)
Diluted (in Dollars per share)	$ 0.03	$ 0.01	$ 0.01	$ (0.01)
Weighted average number of shares outstanding
Basic (in Shares)	92,350,506	90,104,659	91,999,079	90,104,659
Diluted (in Shares)	120,664,362	90,722,106	103,712,786	90,104,659
Preferred Class A [Member]
Preferred stock dividends in arrears
Series A preferred	$ (51,424)	$ (51,424)	$ (102,283)	$ (102,283)
Total preferred stock dividends	(51,424)	(51,424)	(102,283)	(102,283)
Cost of Goods Sold, Including Reimbursable Expenses [Member]
Cost of goods sold	$ 1,049,948	$ 967,775	$ 2,401,545	$ 1,831,050

Condended Consolidated Statemen

Condended Consolidated Statements of Comprehensive Income/(Loss) (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net income/(loss) attributable to common stockholders	$ 4,627,529	$ 580,640	$ 1,821,485	$ (979,099)
Other comprehensive income/(loss)
Change in foreign currency translation adjustment	21,926	(16,289)	(83,531)	(23,952)
Other comprehensive income/(loss)	21,926	(16,289)	(83,531)	(23,952)
Comprehensive income/(loss)	$ 4,649,455	$ 564,351	$ 1,737,954	$ (1,003,051)

Condensed Consolidated Stateme6

Condensed Consolidated Statement of Shareholders' (Deficit) (Unaudited) - USD ($)	Series A Preferred Stock [Member]Series A Preferred Stock [Member]	Series B Preferred Stock [Member]Series B Preferred Stock [Member]	Series C Preferred Stock [Member]Series C Preferred Stock [Member]	Series D Preferred Stock [Member]Series D Preferred Stock [Member]	Additional Paid In Capital, Preferred [Member]	Common Stock [Member]	Additional Paid In Capital, Common [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance at Dec. 31, 2013	$ 4,125	$ 0	$ 0	$ 250	$ 4,717,804	$ 90,105	$ 37,334,358	$ (73,519,917)	$ (87,604)	$ (31,460,879)
Balance (in Shares) at Dec. 31, 2013	4,125,224	0	0	250,000		90,104,659
Employee stock option expense							63,654			63,654
Foreign currency translation adjustment									(156,223)	(156,223)
Restricted stock issuance						$ 1,400	236,600			$ 238,000
Restricted stock issuance (in Shares)						1,400,000
Issuance of common stock, stock option exercise (in Shares)										150,000
Cashless issuance of common stock, stock option exercise						$ 57	(57)			$ 0
Cashless issuance of common stock, stock option exercise (in Shares)						57,143
Net loss for the period	$ 0	$ 0	$ 0	$ 0	0	$ 0	0	(4,459,384)	0	(4,459,384)
Balance at Dec. 31, 2014	$ 4,125	$ 0	$ 0	$ 250	4,717,804	$ 91,562	37,634,555	(77,979,301)	(243,827)	(35,774,832)
Balance (in Shares) at Dec. 31, 2014	4,125,224	0	0	250,000		91,561,802
Employee stock option expense							23,307			23,307
Foreign currency translation adjustment									(83,531)	(83,531)
Restricted stock issuance						$ 1,025	246,925			247,950
Restricted stock issuance (in Shares)						1,025,000
Issuance of common stock, stock option exercise						$ 253	26,997			$ 27,250
Issuance of common stock, stock option exercise (in Shares)						252,500				282,500
Cashless issuance of common stock, stock option exercise						$ 6	(6)			$ 0
Cashless issuance of common stock, stock option exercise (in Shares)						5,800
Net loss for the period	$ 0	$ 0	$ 0	$ 0	0	$ 0	0	1,923,768	0	1,923,768
Balance at Jun. 30, 2015	$ 4,125	$ 0	$ 0	$ 250	$ 4,717,804	$ 92,846	$ 37,931,778	$ (76,055,533)	$ (327,358)	$ (33,636,088)
Balance (in Shares) at Jun. 30, 2015	4,125,224	0	0	250,000		92,845,102

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)	$ 4,678,953	$ 632,064	$ 1,923,768	$ (876,816)	$ (4,459,384)
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities
Change in derivative liabilities	(5,590,517)	(2,257,688)	(4,072,798)	(2,802,571)
Interest expense from derivative instruments			330,266	302,890
Employee stock compensation			116,920	77,540
Provision for doubtful accounts	14,972	55,648	(5,402)	76,002	147,543
Depreciation and amortization			128,742	145,660
Changes in operating assets and liabilities
Accounts receivable			418,215	(2,896,378)
Prepaid expenses			63,497	35,513
Other current assets			5,658	0
Other assets			1,222	(8,771)
Accounts payable and accrued expenses			900,005	628,803
Patent settlement liability			(160,177)	(142,316)
Deferred revenue			329,986	4,721,369
Net cash (used in) operating activities			(20,098)	(739,075)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment			(298,489)	(26,214)
Net cash (used in) investing activities			(298,489)	(26,214)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of notes payable			(25,000)	(20,925)
Proceeds from revolving line of credit			1,000,000	500,000
Proceeds from exercise of stock options			27,250	0
Net cash provided by financing activities			1,002,250	479,075
Effect of exchange rate changes on fixed and intangible assets			63,042	0
Effect of exchange rate changes on cash and cash equivalents			(83,531)	(23,952)
Net increase/(decrease) in cash and cash equivalents			663,174	(310,166)
Cash and cash equivalents at beginning of period			522,914	1,160,720	1,160,720
Cash and cash equivalents at end of period	$ 1,186,088	$ 850,554	1,186,088	850,554	$ 522,914
Cash paid during the period for:
Income taxes			385	33,961
Interest			528,823	594,873
Notes Payable Issued for Existing Notes Payable [Member]
Non-cash transactions:
Notes payable issued in exchange for existing notes payable			14,874,000	1,902,500
Restricted Stock [Member]
Non-cash transactions:
Restricted stock issuance			247,950	0
Promasys B.V. [Member]
Non-cash transactions:
Promissory notes issued for accrued interest			$ 670,000	$ 980,000

Note 1 - Organization and Natur

Note 1 - Organization and Nature of Operations	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Nature of Operations [Text Block]	NOTE 1: ORGANIZATION AND NATURE OF OPERATIONS OmniComm Systems, Inc. (“OmniComm” or the “Company”) is a healthcare technology company that provides web-based electronic data capture (“EDC”) solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations (“CROs”), and other clinical trial sponsors principally located in the United States, Europe and East Asia. Our proprietary EDC software applications; TrialMaster ® , TrialOne ® , eClinical Suite, and Promasys ® Our ability to compete within the EDC industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through our EDC Software and services. Our research and development (“R&D”) efforts are focused on developing new and complementary software solutions, as well as enhancing our existing software solutions through the addition of increased functionality. During the six month periods ended June 30, 2015 and June 30, 2014 we spent approximately $1,355,783 and $1,417,358, respectively, on R&D activities, which are primarily comprised of salaries to our developers and other R&D personnel and related costs associated with the development of our software products.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company’s accounts include those of all its wholly-owned subsidiaries, which are more fully described in the Company’s 2014 Annual Report filed on Form 10-K with the Securities and Exchange Commission, and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation. UNAUDITED FINANCIAL STATEMENTS The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to such rules and regulations, certain financial information and footnote disclosures normally included in the consolidated financial statements have been condensed or omitted. The results for the periods indicated are unaudited, but reflect all adjustments (consisting only of normally recurring adjustments) which management considers necessary for a fair presentation of operating results. The operating results for the six month period ended June 30, 2015 are not necessarily indicative of the results that may be expected for the year-ended December 31, 2015. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year-ended December 31, 2014. ESTIMATES IN FINANCIAL STATEMENTS The preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may differ from those estimates. Reclassifications Certain reclassifications have been made in the 2014 financial statements to conform to the 2015 presentation. These reclassifications did not have any effect on our net income/(loss) or shareholders’ deficit. foreign currency translation The financial statements of the Company’s foreign subsidiaries are translated in accordance with Accounting Standards Codification (“ASC”) 830-30, Foreign Currency Matters—Translation of Financial Statements REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne , eClinical Suite Promasys . TrialMaster eClinical Suite The Company recognizes revenues when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) the product or service has been provided to the customer; (3) the collection of fees is probable; and (4) the amount of fees to be paid by the customer is fixed or determinable. The Company operates in one reportable segment which is the delivery of EDC Software and services to clinical trial sponsors. The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four main activities , including hosted applications, licensing, professional services and maintenance-related services. Hosted Application Revenues The Company offers its TrialMaster eClinical Suite TrialOne Promasys TrialMaster eClinical Suite Revenues resulting from TrialMaster eClinical Suite Fees charged for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first and third stages of the service are typically billed based upon milestones. Revenues earned upon completion of a contractual milestone are deferred and recognized over the estimated remaining hosting period. Fees for application hosting and related services in the second stage are generally billed monthly or quarterly in advance. Revenues resulting from hosting services for the eClinical Suite Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC Software products with its customers for three to five year periods, although customers have entered into both longer and shorter term license agreements. These arrangements typically include multiple elements: software license, consulting services and customer support. The Company bills its customers in accordance with the terms of the underlying contract. Generally, the Company bills license fees in advance for each billing cycle of the license term, which typically is either on a quarterly or annual basis. Payment terms are generally net 30 days. In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may, in the future, do so for new customers based on customer requirements or market conditions. The Company has established vendor specific objective evidence of fair value for the customer support. Accordingly, license revenues are recognized upon delivery of the software and when all other revenue recognition criteria are met. Customer support revenues are recognized ratably over the term of the underlying support arrangement. The Company generates customer support and maintenance revenues from its perpetual license customer base. Professional Services The Company may also enter into arrangements to provide consulting services separate from a license arrangement. In these situations, revenue is recognized on a time-and-materials basis. Professional services can be deemed to be as essential to the functionality of the software at inception and typically are for initial trial configuration, implementation planning, loading of software, building simple interfaces, running test data and documentation of procedures. Subsequent additions or extensions to license terms do not generally include additional professional services. Pass-through Revenue and Expense The Company accounts for pass-through revenue and expense in accordance with ASC 605-45, Principal Agent Considerations Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the periods ended June 30, 2015 and June 30, 2014, respectively are: For the six months ended June 30, 2015 June 30, 2014 Revenue activity Set-up fees $ 2,882,153 $ 1,943,854 Change orders 354,808 196,954 Maintenance 2,501,407 2,011,646 Software licenses 1,527,374 1,286,147 Professional services 1,924,967 952,805 Hosting 482,317 399,618 Total $ 9,673,026 $ 6,791,024 For the three months ended June 30, 2015 June 30, 2014 Revenue activity Set-up fees $ 1,617,609 $ 1,136,021 Change orders 212,767 83,866 Maintenance 1,269,530 1,052,015 Software licenses 786,437 618,830 Professional services 707,970 508,298 Hosting 240,586 209,719 Total $ 4,834,899 $ 3,608,749 COST OF REVENUES Cost of revenues primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits, and bonuses for the Company’s professional services staff. Cost of revenues also includes outside service provider costs . CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 days or less. The carrying amount reported in the accompanying consolidated balance sheets approximates fair value. ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $99,083 as of June 30, 2015 and $186,085 as of December 31, 2014, respectively. The following table summarizes activity in the Company's allowance for doubtful accounts for the periods presented. June 30, 2015 December 31, 2014 Beginning of period $ 186,085 $ 65,341 Bad debt expense (5,402 ) 147,543 Write-offs (81,600 ) (26,875 ) Exchange rate impact -0- 76 End of period $ 99,083 $ 186,085 Concentration of Credit Risk Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one financial institution may be in excess of FDIC-insured limits. As of June 30, 2015, $795,717 was deposited in excess of FDIC-insured limits. Management believes the risk in these situations to be minimal. Except as follows, the Company has no significant off-balance-sheet risk or credit risk concentrations. Financial instruments that subject the Company to potential credit risks are principally cash equivalents and accounts receivable. Concentrated credit risk with respect to accounts receivable is limited to creditworthy customers. The Company's customers are principally located in the United States , Europe and East Asia. The Company is directly affected by the overall financial condition of the pharmaceutical, biotechnology and medical device industries and management believes that credit risk exists and that any credit risk the Company faces has been adequately reserved for as of June 30, 2015. The Company maintains an allowance for doubtful accounts based on accounts past due according to contractual terms and historical collection experience. Actual losses , when incurred , are charged to the allowance. The Company's losses related to collection of accounts receivable have consistently been within management's expectations. As of June 30, 2015, the Company believes no additional credit risk exists beyond the amounts provided for in our allowance for uncollectible accounts. The Company evaluates its allowance for uncollectable accounts on a quarterly basis based on a specific review of receivable aging and the period that any receivables are beyond the standard payment terms. The Company does not require collateral from its customers in order to mitigate credit risk. One customer accounted for 13% of our revenues during the six month period ended June 30, 2015 or approximately $1,249,000. One customer accounted for 13% of our revenues during the six month period ended June 30, 2014 or approximately $856,000. The following table summarizes the number of customers who individually comprise greater than 10% of total revenue and/or total accounts receivable and their aggregate percentage of the Company's total revenue and gross accounts receivable for the periods presented. Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable June 30, 2015 1 13% 2 31% December 31, 2014 1 15% 1 18% June 30, 2014 1 13% 2 32% The table below provides revenues from European customers for the six month periods ended June 30, 2015 and June 30, 2014, respectively. European revenues For the six months ended June 30, 2015 June 30, 2014 European revenues % of Total revenues European revenues % of Total revenues $ 1,084,178 11% $ 1,296,534 19% The Company serves all of its hosting customers from third-party web hosting facilities located in the United States. The Company does not control the operation of these facilities, and they are vulnerable to damage or interruption. The Company maintains redundant systems that can be used to provide service in the event the third-party web hosting facilities become unavailable, although in such circumstances, the Company's service may be interrupted during the transition. PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 years for leasehold improvements, computers, equipment and furniture and 3 years for software. Gains or losses on disposal are charged to operations. ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations ASC 350, Intangibles- Goodwill and Other The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no more for an asset than its replacement or reproduction cost. The market approach estimates value based on what other participants in the market have paid for reasonably similar assets. Although each valuation approach is considered in valuing the assets acquired, the approach ultimately selected is based on the characteristics of the asset and the availability of information. Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment has occurred typically requires various estimates and assumptions, including determining which cash flows are directly related to the potentially impaired asset, the useful life over which cash flows will occur, their amount and the asset’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value. FAIR VALUE MEASUREMENT OmniComm’s capital structure includes the use of warrants and convertible debt features that are classified as derivative financial instruments. Derivative financial instruments are recognized as either assets or liabilities and are measured at fair value under ASC 815 , Derivatives and Hedging . , Fair Value Measurements and Disclosures DEFERRED REVENUE Deferred revenue represents cash advances and amounts in accounts receivable as of the balance sheet date received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may include an initial payment at the time the contract is executed, with future payments dependent upon the completion of certain contract phases or targeted milestones. In the event of contract cancellation, the Company is generally entitled to payment for all work performed through the point of cancellation. As of June 30, 2015, the Company had $8,563,929 in deferred revenues relating to contracts for services to be performed over periods ranging from one month to 5.8 years. The Company had $6,696,830 in deferred revenues that are expected to be recognized in the next twelve fiscal months. ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $406,502 and $228,530 for the six month periods ended June 30, 2015 and June 30, 2014, respectively and are included under selling, general and administrative expenses in our unaudited condensed consolidated financial statements. RESEARCH AND DEVELOPMENT EXPENSES Software development costs are included in R&D and are expensed as incurred. ASC 985-20, Software Industry Costs of Software to Be Sold, Leased or Marketed EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2009 Equity Incentive Plan (the “2009 Plan”) was approved at our Annual Meeting of Shareholders on July 10, 2009. The 2009 Plan provides for the issuance of up to 7,500,000 shares to employees, directors and key consultants. The predecessor plan, the OmniComm Systems, Inc., 1998 Stock Incentive Plan (the “1998 Plan”) expired on December 31, 2008. The 1998 Plan provided for the issuance of up to 12 ,5 00,000 shares in accordance with the terms of the 1998 Plan document. Each plan is more fully described in “Note 14, Employee Equity Incentive Plans”. The Company accounts for its employee equity incentive plans under Compensation – Stock Compensation ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value. EARNINGS PER SHARE The Company accounts for Earnings per Share using ASC 260, Earnings per Share . Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities. INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, Income Taxes . Valuation allowances are established when necessary to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities. IMPACT OF NEW ACCOUNTING STANDARDS During the first six months of 2015, we adopted the following new accounting pronouncements: In May 2014, FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” consolidated financial statements. In August 2014, FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” , (“ASU 2014-15”), which requires management to evaluate, in connection with preparing financial statements for each annual and interim reporting period, whether there are conditions or events, considered in the aggregate, that raise substantial doubt about an entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable) and provide related disclosures. ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. We believe the adoption of this guidance will not have a material effect on our consolidated financial statements . Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note 3 - Going Concern

Note 3 - Going Concern	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	NOTE 3: GOING CONCERN We have experienced net losses and negative cash flows from operations and have utilized debt and equity financings to help provide for our working capital, capital expenditure and R&D needs. We will continue to require substantial funds to continue our R&D activities and to market, sell and commercialize our technology. We may need to raise substantial additional capital to fund our future operations. Our capital requirements will depend on many factors, including the following: problems, delays, expenses and complications frequently encountered by companies developing and commercializing new technologies; the progress of our R&D activities; the rate of technological advances; determinations as to the commercial potential of our technology under development; the status of competitive technology; the establishment of collaborative relationships; the success of our sales and marketing programs; and other changes in economic, regulatory or competitive conditions in our planned business. Estimates about the adequacy of funding for our activities are based upon certain assumptions, including assumptions that the R&D programs relating to our technology can be conducted at projected costs and that progress towards the commercialization of our technology will be timely and successful. There can be no assurance that changes in our R&D plans, acquisitions or other events will not result in accelerated or unexpected expenditures. To satisfy our capital requirements, we may seek additional financing through debt and equity financings. There can be no assurance that any such funding will be available to us on favorable terms or at all. If adequate funds are not available when needed, we may be required to delay, scale back or eliminate some or all of our research and product development and marketing programs. If we are successful in obtaining additional financings, the terms of such financings may have the effect of diluting or adversely affecting the holdings or the rights of the holders of our common and preferred stock or result in increased interest expense in future periods. The ability of the Company to continue in existence is dependent on its having sufficient financial resources to bring products and services to market for marketplace acceptance. As a result of our historical operating losses, negative cash flows and accumulated deficits for the period ending June 30, 2015 there is substantial doubt about the Company’s ability to continue as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Note 4 - Earnings_(Loss) Per Sh

Note 4 - Earnings/(Loss) Per Share	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE 4 : EARNINGS/ (LOSS) PER SHARE Basic earnings/(loss) per share were calculated using the weighted average number of shares outstanding of 91,999,079 and 90,104,659 for the six month periods ended June 30, 2015 and June 30, 2014, respectively. The outstanding share balance as of June 30, 2015 and June 30, 2014, respectively, includes 2,866,681 and 850,007 restricted shares that have been issued but are still at risk of forfeiture as the restrictions have not lapsed. Antidilutive shares of 71,302,468 and 82,066,327 have been omitted from the calculation of dilutive earnings/(loss) per share for the six month periods ended June 30, 2015 and June 30, 2014, respectively, as the shares were antidilutive. Provided below is the reconciliation between numerators and denominators of the basic and diluted earnings per shares. The table below provides a reconciliation of anti-dilutive securities outstanding as of June 30, 2015 and June 30, 2014, respectively. Anti-dilutive security June 30, 2015 June 30, 2014 Preferred stock 2,750,149 2,750,149 Employee stock options 1,563,793 5,275,000 Warrants 52,263,517 48,463,517 Convertible notes 13,850,000 24,620,000 Shares issuable for accrued interest 875,009 957,661 Total 71,302,468 82,066,327 The employee stock options are exercisable at prices ranging from $0.045 to $0.50 per share. The exercise prices on the warrants range from $0.25 to $0.60 per share. Shares issuable upon conversion of Convertible Debentures have conversion prices ranging from $0.25 to $0.50 per share. Some of the Company’s convertible debt and convertible preferred stock have an anti-dilutive effect on net income/(loss) per share and were not included in the computation of diluted earnings per share. For the six months ended June 30, 2015 June 30, 2014 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 1,821,485 91,999,079 $ 0.02 $ (979,099 ) 90,104,659 $ (0.01 ) Effect of dilutive securities - (387,828 ) 11,713,707 (0.03 ) -0- -0- -0- Diluted EPS $ 1,433,657 103,712,786 $ 0.01 $ (979,099 ) 90,104,659 $ (0.01 ) For the three months ended June 30, 2015 June 30, 2014 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 4,627,529 92,350,506 $ 0.05 $ 580,640 90,104,659 $ 0.01 Effect of dilutive securities - (1,460,161 ) 28,313,856 (0.05 ) -0- 617,447 -0- Diluted EPS $ 3,167,368 120,664,362 $ 0.03 $ 580,640 90,722,106 $ 0.01 See Item 5. Other Information

Note 5 - Property and Equipment

Note 5 - Property and Equipment, Net	6 Months Ended
	Jun. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 5: PROPERTY AND EQUIPMENT, NET Property and equipment consists of the following: June 30, 2015 December 31, 2014 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 1,903,386 $ 1,546,029 $ 357,357 $ 1,880,183 $ 1,482,737 $ 397,446 5 Leasehold improvements 92,246 84,796 7,450 92,504 82,353 10,151 5 Computer software 1,852,482 1,569,680 282,802 1,580,640 1,528,418 52,222 3 Office furniture 112,034 105,306 6,728 113,365 105,048 8,317 5 Total $ 3,960,148 $ 3,305,811 $ 654,337 $ 3,666,692 $ 3,198,556 $ 468,136 Depreciation expense for the six month periods ended June 30, 2015 and June 30, 2014 was $108,505 and $122,433, respectively.

Note 6 - Intangible Assets, at

Note 6 - Intangible Assets, at Cost	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	NOTE 6: INTANGIBLE ASSETS, AT COST Intangible assets consist of the following: June 30, 2015 December 31, 2014 Asset Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical customer lists $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer lists 110,742 12,305 98,437 120,305 9,357 110,948 15 Promasys B.V. software code 72,837 24,279 48,558 72,837 16,995 55,842 5 Promasys B.V. URLs/Website 55,930 31,072 24,858 60,760 23,629 37,131 3 Total $ 1,632,210 $ 1,460,357 $ 171,853 $ 1,646,603 $ 1,442,682 $ 203,921 Amortization expense was $20,237 and $23,227 for the six month periods ended June 30, 2015 and June 30, 2014, respectively. Remaining amortization expense for the Company’s intangible assets is as follows: 2015 $ 20,297 2016 37,486 2017 21,950 2018 19,522 2019 7,383 Thereafter 65,215 Total $ 171,853

Note 7 - Accounts Payable and A

Note 7 - Accounts Payable and Accrued Expenses	6 Months Ended
	Jun. 30, 2015
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 7: ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following: Account June 30, 2015 December 31, 2014 Accounts payable $ 823,291 $ 613,584 Accrued payroll and related costs 438,048 319,629 Other accrued expenses 79,159 85,248 Accrued interest 783,692 875,724 Total accounts payable and accrued expenses $ 2,124,190 $ 1,894,185

Note 8 - Line of Credit and Not

Note 8 - Line of Credit and Notes Payable	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 8: LINES OF CREDIT AND NOTES PAYABLE On March 18, 2013, the Company entered into a $2,000,000 revolving Line of Credit (“Line of Credit”) with The Northern Trust Company guaranteed by our Chief Executive Officer and Director , Cornelis F. Wit. Mr. Wit receives 2.0% interest (approximately $9,500 per month) from the Company on the assets pledged for the Line of Credit. On December 18, 2013 the Company renewed the Line of Credit and increased the available balance to $4,000,000. On February 3, 2015 the Company renewed the Line of Credit and increased the available balance to $5,000,000. The Line of Credit matures on February 2, 2018 and carries a variable interest rate based on the prime rate. At June 30, 2015, $5,000,000 was outstanding on the Line of Credit at an interest rate of 2.25%. At June 30, 2015, the Company owed $7,731,500 in notes payable all of which are unsecured. The table below provides details as to the terms and conditions of the notes payable. Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate June 30, 2015 Current term Current term 1/1/2014 4/1/2017 12% $ 980,000 $ -0- $ -0- $ -0- $ 980,000 4/4/2014 4/1/2017 12% 1,600,000 -0- -0- -0- 1,600,000 4/4/2014 4/1/2017 12% 45,000 -0- 45,000 -0- -0- 4/4/2014 4/1/2017 12% 137,500 -0- 137,500 -0- -0- 4/4/2014 4/1/2017 10% 120,000 -0- 120,000 -0- -0- 12/1/2014 4/1/2017 10% 300,000 -0- 300,000 -0- -0- 12/1/2014 4/1/2017 12% 90,000 -0- 90,000 -0- -0- 12/1/2014 4/1/2017 12% 100,000 -0- 100,000 -0- -0- 1/31/2015 4/1/2017 12% 2,860,000 -0- -0- -0- 2,860,000 1/31/2015 4/1/2017 12% 529,000 -0- -0- -0- 529,000 1/31/2015 4/1/2017 12% 950,000 -0- -0- -0- 950,000 4/1/2015 4/1/2018 12% 20,000 -0- -0- -0- 20,000 Discount on note payable -0- -0- -0- (1,106,070 ) Total $ 7,731,500 $ -0- $ 792,500 $ -0- $ 5,832,930 At December 31, 2014, the Company owed $7,081,500 in notes payable all of which were unsecured. The table below provides details as to the terms and conditions of the notes payable. Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2014 Current term Current term 1/1/2013 1/1/2016 12% $ 529,000 $ -0- $ -0- $ -0- $ 529,000 2/22/2013 1/1/2016 12% 20,000 -0- -0- -0- 20,000 4/1/2013 3/31/2016 12% 2,860,000 -0- -0- -0- 2,860,000 1/1/2014 4/1/2017 12% 980,000 -0- -0- -0- 980,000 4/4/2014 4/1/2017 12% 1,600,000 -0- -0- -0- 1,600,000 4/4/2014 4/1/2017 12% 45,000 -0- 45,000 -0- -0- 4/4/2014 4/1/2017 12% 137,500 -0- 137,500 -0- -0- 4/4/2014 4/1/2017 10% 120,000 -0- 120,000 -0- -0- 12/1/2014 4/1/2017 10% 300,000 -0- 300,000 -0- -0- 12/1/2014 4/1/2017 12% 90,000 -0- 90,000 -0- -0- 12/1/2014 4/1/2017 12% 100,000 -0- 100,000 -0- -0- 12/17/2014 1/1/2016 12% 20,000 -0- 20,000 -0- -0- 12/23/2014 4/1/2017 12% 280,000 -0- -0- -0- 280,000 Discount on note payable -0- -0- -0- (568,209 ) Total $ 7,081,500 $ -0- $ 812,500 $ -0- $ 5,700,791 On January 1, 2014, the Company issued a promissory note in the principal amount of $980,000 and warrants to purchase 3,920,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of April 1, 2017 to our Chief Executive Officer and Director, Cornelis F. Wit, in exchange for accrued interest in the amount of $980,000. The note carries an interest rate of 12% per annum and is due on April 1, 2017. This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $628,086 was calculated and allocated to the warrants and recorded as a liability to the issuance of the note payable. As a result of the liability we recorded a discount to the note payable. The carrying amount of the note at the time of issuance was therefore $351,914. The warrant liability (discount) will be amortized over the 39 month duration of the note payable. The Company will continue to perform a fair value calculation quarterly on the warrant liability and accordingly the warrant liability is increased or decreased based on the fair value calculation. The resulting increase or decrease is reflected in operations as an unrealized gain or loss on changes in derivative liabilities. On April 4, 2014 the Company issued a promissory note payable to our Chief Executive Officer and Director, Cornelis F. Wit, in the amount of $1,600,000 in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of April 1, 2017 . The expiration date of the warrants associated with the prommissory note was also extended to April 1, 2017. On April 4, 2014 the Company issued a promissory note in the amount of $45,000 in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of April 1, 2017 . On April 4, 2014 the Company issued a promissory note in the amount of $137,500 in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of April 1, 2017 . On April 4, 2014 the Company issued a promissory note in the amount of $120,000 and paid $3,424 in principal in exchange for an existing promissory note in the amount of $123,424. The promissory note carries an interest rate of 10% and has a maturity date of April 1, 2017 . On December 1, 2014 the Company issued a promissory note in the amount of $300,000 and paid $8,562 in principal in exchange for an existing promissory note in the amount of $308,562. The promissory note carries an interest rate of 10% and has a maturity date of April 1, 2017 . On December 1, 2014 the Company issued a promissory note in the amount of $90,000 in exchange for accrued interest in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of April 1, 2017. On December 1, 2014 the Company issued a promissory note in the amount of $100,000 in exchange for accrued interest in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of April 1, 2017. On December 17, 2014 the Company issued a promissory note in the amount of $20,000 in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of January 1, 2016. On June 15, 2015 the Company paid $20,000 in exchange for the outstanding note payable in the same amount. On December 23, 2014, the Company issued a promissory note in the amount of $280,000 to our Chief Executive Officer and Director, Cornelis F. Wit. The note carries an interest rate of 12% per annum and is due on April 1, 2017. On January 31, 2015 the Company issued a promissory note in the amount of $2,860,000 and paid $6,879 in principal to our Chief Executive Officer and Director, Cornelis F. Wit, in exchange for an existing promissory note in the amount of $2,866,879. The promissory note carries an interest rate of 12% and has a maturity date of April 1, 2017. The expiration date of the warrants associated with the promissory note was also extended to April 1, 2017. On January 31, 2015 the Company issued a promissory note in the amount of $529,000 to our Chief Executive Officer and Director, Cornelis F. Wit, in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of April 1, 2017. The expiration date of the warrants associated with the promissory note was also extended to April 1, 2017. On January 31, 2015, the Company issued a promissory note in the principal amount of $950,000 and warrants to purchase 3,800,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of April 1, 2017 to our Chief Executive Officer and Director, Cornelis F. Wit, in exchange for an existing promissory note in the amount of $280,000 and accrued interest in the amount of $670,000. The note carries an interest rate of 12% per annum and is due on April 1, 2017. This issuance caused us to calculate and record a derivative liability for the warrant liability. The warrants were valued using the Black Scholes option pricing model. A value of $868,127 was calculated and allocated to the warrants and recorded as a liability to the issuance of the note payable. As a result of the liability we recorded a discount to the note payable. The carrying amount of the note at the time of issuance was therefore $81,873. The warrant liability (discount) will be amortized over the 26 month duration of the note payable. The Company will continue to perform a fair value calculation quarterly on the warrant liability and accordingly the warrant liability is increased or decreased based on the fair value calculation. The resulting increase or decrease is reflected in operations as an unrealized gain or loss on changes in derivative liabilities. On April 1, 2015 the Company issued a promissory note in the amount of $20,000 to our Chairman and Chief Technology Officer, Randall G. Smith, in exchange for an existing promissory note in the same amount. The promissory note carries an interest rate of 12% and has a maturity date of April 1, 2018.

Note 9 - Convertible Notes Paya

Note 9 - Convertible Notes Payable	6 Months Ended
	Jun. 30, 2015
Convertible Debt Disclosure [Abstract]
Convertible Debt Disclosure [Text Block]	NOTE 9: CONVERTIBLE NOTES PAYABLE The following table summarizes the convertible debt outstanding as of June 30, 2015 . Principal Discount Carrying amount Carrying amount at Total at at Short term Long term Date of Maturity Interest Original June 30, Allocated discount June 30, June 30, Related Non Related Non related 8/1/1999 6/30/2004 10% $ 862,500 $ 75,000 $ -0- $ -0- $ -0- $ 75,000 $ -0- $ 75,000 $ -0- $ -0- 8/29/2008 4/1/2017 10% 150,000 150,000 135,600 135,600 -0- 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2017 10% 2,120,000 1,770,000 1,916,480 1,916,480 -0- 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2017 12% 260,000 260,000 70,200 70,200 -0- 260,000 -0- -0- -0- 260,000 12/16/2008 4/1/2017 12% 4,570,000 4,475,000 1,233,900 1,233,900 -0- 4,475,000 -0- -0- 4,475,000 -0- 12/16/2008 4/1/2018 12% 215,000 215,000 58,050 58,050 -0- 215,000 -0- -0- -0- 215,000 12/16/2008 4/1/2018 12% 25,000 25,000 6,750 6,750 -0- 25,000 -0- -0- 25,000 -0- 9/30/2009 4/1/2017 12% 1,300,000 1,100,000 488,800 488,800 -0- 1,100,000 -0- -0- 1,100,000 -0- 9/30/2009 4/1/2018 12% 100,000 100,000 37,600 37,600 -0- 100,000 -0- -0- -0- 100,000 12/31/2009 4/1/2017 12% 1,440,000 1,440,000 904,320 904,320 -0- 1,440,000 -0- -0- 1,440,000 -0- 12/31/2009 4/1/2018 12% 50,000 50,000 31,400 31,400 -0- 50,000 -0- -0- -0- 50,000 Total $ 11,092,500 $ 9,660,000 $ 4,883,100 $ 4,883,100 $ -0- $ 9,660,000 $ 0 $ 75,000 $ 8,810,000 $ 775,000 The following table summarizes the convertible debt outstanding as of December 31, 2014 . Principal Discount Carrying Carrying amount at Total at amount Short term Long term Date of Maturity Interest Original December Allocated discount December December Related Non related Related Non related 8/1/1999 6/30/2004 10% $ 862,500 $ 75,000 $ -0- $ -0- $ -0- $ 75,000 $ -0- $ 75,000 $ -0- $ -0- 8/29/2008 1/1/2016 10% 2,120,000 1,770,000 1,916,480 1,916,480 -0- 1,770,000 -0- -0- 1,770,000 -0- 8/29/2008 4/1/2016 10% 150,000 150,000 135,600 135,600 -0- 150,000 -0- -0- -0- 150,000 12/16/2008 1/1/2016 12% 375,000 375,000 101,250 101,250 -0- 375,000 -0- -0- -0- 375,000 12/16/2008 1/1/2016 12% 4,600,000 4,505,000 1,242,000 1,242,000 -0- 4,505,000 -0- -0- 4,505,000 -0- 12/16/2008 4/1/2016 12% 100,000 100,000 27,000 27,000 -0- 100,000 -0- -0- -0- 100,000 9/30/2009 1/1/2016 12% 100,000 100,000 37,600 37,600 -0- 100,000 -0- -0- -0- 100,000 9/30/2009 1/1/2016 12% 1,300,000 1,100,000 488,800 488,800 -0- 1,100,000 -0- -0- 1,100,000 -0- 12/31/2009 1/1/2016 12% 50,000 50,000 31,400 31,400 -0- 50,000 -0- -0- -0- 50,000 12/31/2009 1/1/2016 12% 1,440,000 1,440,000 904,320 904,320 -0- 1,440,000 -0- -0- 1,440,000 -0- Total $ 11,097,500 $ 9,665,000 $ 4,884,450 $ 4,884,450 $ -0- $ 9,665,000 $ -0- $ 75,000 $ 8,815,000 $ 775,000 10% Convertible Notes During 1999, the Company issued 10% Convertible Notes payable in the amount of $862,500 pursuant to a private offering. There were costs of $119,625 associated with this offering. The net proceeds to the Company were $742,875. The notes bear interest at ten percent annually, payable semi-annually. The notes were convertible after maturity, which was June 30, 2004, into shares of common stock of the Company at $1.25 per share. As of June 30, 2015, $787,500 of the Convertible Notes had been repaid in cash or converted into 1,495,179 shares of common stock of the Company leaving an outstanding principal balance of $75,000 that is in default. There was $120,968 of accrued interest at June 30, 2015. Secured Convertible Debentures On September 30, 2009, the Company sold an aggregate of $1,400,000 principal amount 12% Secured Convertible Debentures (the “Debentures”) and common stock purchase warrants (the “Warrants”) to purchase an aggregate of 5,600,000 shares of our common stock exercisable at a price of $0.25 per share for four years subsequent to the closing of the transaction to four accredited investors including our Chief Executive Officer and Director, Cornelis F. Wit. The Debentures, which bear interest at 12% per annum, matured on March 30, 2011. The Debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.25 per share. The debentures are secured by all of the assets of the Company. On March 30, 2011, the Company repaid $200,000 of the outstanding principal amounts owed and extended $1,200,000 of the convertible debentures until April 1, 2013, including $1,100,000 in convertible debentures held by our Chief Executive Officer and Director, Cornelis F. Wit. The Company also extended the expiration date of the warrants associated with the offering until September 30, 2015. On February 22, 2013 the Company and the lenders agreed to extend the maturity date of $1,200,000 of the convertible debentures including $1,100,000 due to our Chief Executive Officer and Director, Cornelis F. Wit to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. As part of Amendment Number Two to Securities Purchase Agreement, Mr. Wit agreed to waive his rights to the granted Security Interest and for the release of the Collateral. On January 31, 2015 the Company and Mr. Wit extended the maturity date of the $1,100,000 of convertible debentures to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017. On April 1, 2015 the Company and the lender extended the maturity date of $100,000 of convertible debentures, originally issued in September 2009. The debentures carry an interest rate of 12% and have a maturity date of April 1, 2018. The expiration date of the warrants associated with the debentures was also extended to April 1, 2018. Convertible Debentures On August 29, 2008, the Company sold $2,270,000 of convertible debentures and warrants to purchase an aggregate of 4,540,000 shares of our common stock to four accredited investors including our Chief Executive Officer and Director, Cornelis F. Wit , and Guus van Kesteren, a Director of the Company. The convertible debentures, which bear interest at 10% per annum, were due on August 29, 2010. The convertible debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.50 per share. On September 30, 2009, Mr. Wit and Mr. van Kesteren extended $1,920,000 of the convertible debentures until August 29, 2013 in accordance with the terms of a Secured Convertible Debenture issued on that date. On February 22, 2013 the Company and Mr. van Kesteren extended the maturity date of $150,000 of the convertible debentures due to Mr. van Kesteren to January 1, 2015. The expiration date of the warrants associated with the debentures was also extended to January 1, 2015. On April 21 , 2014 the Company and Mr. van Kesteren extended the maturity date of $150,000 of the convertible debentures due to Mr. van Kesteren to April 1, 2016. The expiration date of the warrants associated with the debentures was also extended to April 1, 2016. On July 31, 2014 Mr. van Kesteren’s term on the Board of Directors ended. Effective on the same date, his convertible note in the amount of $150,000 was reclassified from Related Party to Non-Related Party. On February 22, 2013 the Company and Mr. Wit extended the maturity date of $1,770,000 of the convertible debentures due to Mr. Wit to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On January 31, 2015 the Company and Mr. Wit extended the maturity date of $1,770,000 of the convertible debentures due to Mr. Wit to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017 . On June 30, 2015 the Company and Mr. van Kesteren extended the maturity date of $150,000 of the convertible debentures due to Mr. van Kesteren to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017 . On December 16, 2008, we sold $5,075,000 of convertible debentures and warrants to purchase an aggregate of 10,150,000 shares of our common stock to eleven accredited investors including our Chief Executive Officer and Director, Chief Operating Officer, Chairman and Chief Technology Officer, Chief Financial Officer and three of our Directors. The convertible debentures, which bear interest at 12% per annum, were due on December 16, 2010. The convertible debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.50 per share. On September 30, 2009 the officers, directors and an affiliate of the Company extended $4,980,000 of Convertible Notes until December 16, 2013 in accordance with the terms of a Secured Convertible Debenture issued on that date. On February 22, 2013 the Company and the lenders agreed to extend the maturity date of $4,505,000 of the convertible debentures including $4,475,000 due to our Chief Executive Officer and Director , Cornelis F. Wit, $25,000 due to our Chief Operating Officer and President , Stephen E. Johnson , and $5,000 due to our Chairman and Chief Technology Officer , Randall G. Smith , to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On February 27, 2013 the Company and Matthew Veatch, a former director of the Company, extended the maturity date of $15,000 of convertible debentures issued to Mr. Veatch to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On March 6, 2013, the Company and the lender agreed to extend the maturity date of $200,000 of convertible debentures to January 1, 2014. The expiration date of the warrants associated with the debentures was also extended to January 1, 2014. On March 12, 2013, the Company and the lender agreed to extend the maturity date of $100,000 of convertible debentures to January 1, 2015. The expiration date of the warrants associated with the debentures was also extended to January 1, 2015. On December 5, 2013 the Company and Guus van Kesteren, a Director of the Company , extended the maturity date of $160,000 of the convertible debentures due to Mr. van Kesteren to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On December 9, 2013, the Company and the lender agreed to extend the maturity date of $200,000 of convertible debentures to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On April 28, 2014, the Company and the lender agreed to extend the maturity date of $100,000 of convertible debentures to April 1, 2016. The expiration date of the warrants associated with the debentures was also extended to April 1, 2016. On July 31, 2014 Mr. van Kesteren’s term on the Board of Directors ended. Effective on the same date, his convertible note in the amount of $160,000 was reclassified from Related Party to Non-Related Party. On January 31, 2015 the Company and Mr. Wit extended the maturity date of $4,475,000 of the convertible debentures due to Mr. Wit to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017 . On April 27, 2015, the Company and the lender extended the maturity date of $200,000 of convertible debentures originally issued in December 2008. The debentures carry an interest rate of 12% and have a maturity date of April 1, 2018. The expiration date of the warrants associated with the debentures was also extended to April 1, 2018. On April 30, 2015 the Company and Mr. Johnson extended the maturity date of $25,000 of convertible debentures, due to our Chief Operating Officer and President, Stephen E. Johnson, originally issued in December 2008. The debentures carry an interest rate of 12% and have a maturity date of April 1, 2018. The expiration date of the warrants associated with the debentures was also extended to April 1, 2018. On May 1, 2015 the Company paid $5,000 to our Chairman and Chief Technology Officer , Randall G. Smith in exchange for his outstanding convertible note in the same amount. On May 1, 2015 the Company and our former Director Guus van Kesteren extended the maturity date of $160,000 of convertible debentures to Mr. van Kesteren, originally issued in December 2008. The debentures carry an interest rate of 12% and have a maturity date of April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017. On May 7, 2015 the Company and our former Director, Matthew Veatch, extended the maturity date of $15,000 of convertible debentures originally issued to Mr. Veatch, in December 2008. The debentures carry an interest rate of 12% and have a maturity date of April 1, 2018. The expiration date of the warrants associated with the debentures was also extended to April 1, 2018. On June 30, 2015, the Company and the lender agreed to extend the maturity date of $100,000 of convertible debentures to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017 . On December 31, 2009, the Company sold an aggregate of $1,490,000 principal amount 12% convertible debentures and warrants to purchase an aggregate of 5,960,000 shares of our common stock exercisable at a price of $0.25 per share for four years subsequent to the closing of the transaction to three accredited investors including our Chief Executive Officer and Director, Cornelis F. Wit. The debentures, which bear interest at 12% per annum, matured on June 30, 2011. The debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.25 per share. On June 30, 2011, the Company and the lenders agreed to extend all $1,490,000 of the convertible debentures until October 1, 2013, including $1,440,000 of the Debentures held by Mr. Wit. The Company also extended the expiration date of the warrants associated with the December 2009 offering until December 31, 2015. On February 22, 2013 the Company and the lenders agreed to extend the maturity date of $1,490,000 of the convertible debentures , including $1,440,000 due to Mr. Wit, to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On January 31, 2015 the Company and Mr. Wit extended the maturity date of $1,440,000 of the convertible debentures due to Mr. Wit to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017 . On April 1, 2015 the Company and the lenders extended the maturity date of $50,000 of convertible debentures, originally issued in December 2009. The debentures carry an interest rate of 12% and have a maturity date of April 1, 2018. The expiration date of the warrants associated with the debentures was also extended to April 1, 2018. The payments required at maturity under the Company’s outstanding convertible debt at June 30, 2015 are as follows: 2015 $ 75,000 2016 -0- 2017 9,195,000 2018 390,000 Total $ 9,660,000

Note 10 - Fair Value Measuremen

Note 10 - Fair Value Measurement	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	NOTE 10: FAIR VALUE MEASUREMENT The Company measures the fair value of its assets and liabilities under the guidance of ASC 820, Fair Value Measurements and Disclosures ASC 820 clarifies that fair value is an exit price, representing the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants based on the highest and best use of the asset or liability. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. ASC 820 requires the Company to use valuation techniques to measure fair value that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized as follows: ● Level 1 ● Level 2 ● Level 3 The valuation techniques that may be used to measure fair value are as follows: A. Market approach B. Income approach C. Cost approach The Company also adopted the provisions of ASC 825, Financial Instruments The Company’s financial assets or liabilities subject to ASC 820 as of June 30, 2015 include the conversion feature and warrant liability associated with convertible debentures issued during 2008 and 2009 and the warrants issued during 2011, 2013, 2014 and 2015 that are associated with notes payable that were issued to our Chief Executive Officer and Director, Cornelis F. Wit. The conversion feature and warrants were deemed to be derivatives (the “Derivative Instruments”) since a fixed conversion price cannot be determined for either of the Derivative Instruments due to anti-dilution provisions embedded in the offering documents for the convertible debentures. The derivative instruments were not issued for risk management purposes and as such are not designated as hedging instruments under the provisions of ASC 815 , Disclosures about Derivative Instruments and Hedging Activities Following is a description of the valuation methodologies used to determine the fair value of the Company’s financial assets including the general classification of such instruments pursuant to the valuation hierarchy. A summary as of June 30, 2015 of the fair value of liabilities measured at fair value on a recurring basis follows: Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs June 30, 2015 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 1,954,155 $ -0- $ -0- $ 1,954,155 Warrant liability 4,480,637 -0- -0- 4,480,637 Total of derivative liabilities $ 6,434,792 $ -0- $ -0- $ 6,434,792 (1) The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the six month period ended June 30, 2015 (2) The fair value at the measurement date is equal to their carrying value on the balance sheet Significant valuation assumptions of derivative instruments at June 30, 2015 Risk free interest rate 0.24% Dividend yield 0.00% Expected volatility 73.8% to 144.0% Expected life (range in years) Conversion feature liability 1.76 to 2.76 Warrant liability 0.51 to 2.76 A summary as of December 31, 2014 of the fair value of liabilities measured at fair value on a recurring ba s Fair value at December 31, Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs 2014 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 2,944,402 $ -0- $ -0- $ 2,944,402 Warrant liability 6,695,060 -0- -0- 6,695,060 Total of derivative liabilities $ 9,639,462 $ -0- $ -0- $ 9,639,462 (1) The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with the following assumptions for the year ended December 31, 2014 (2) The fair value at the measurement date is equal to their carrying value on the balance sheet Significant valuation assumptions of derivative instruments at December 31, 2014 Risk free interest rate 0.13% Dividend yield 0.00% Expected volatility 119.8% to 155.7% Expected life (range in years) Conversion feature liability 1.00 to 1.25 Warrant liability 1.00 to 2.25 A summary as of June 30, 2015 of the fair value of assets measured at fair value on a non-recurring basis follows: Carrying amount December 31, Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs 2014 June 30, 2015 (Level 1) (Level 2) (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 110,948 $ 98,437 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 55,842 48,558 -0- -0- 72,943 Promasys B.V. URLs/website (4) 37,131 24,858 -0- -0- 68,814 Total $ 203,921 $ 171,853 $ -0- $ -0- $ 278,010 (3) The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied. (4) The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction. Other identifiable intangible assets, which are subject to amortization, are being amortized using the straight-line method over their estimated useful lives ranging from 3 to 15 years. The Impairment or Disposal of Long-Lived Asset subsection of ASC 360, Property, Plant and Equipment The Company’s goodwill and other identifiable intangible assets with indefinite lives are measured at fair value on a nonrecurring basis using significant unobservable inputs (Level 3). The table below presents the fair value of the Goodwill as of June 30, 2015 and December 31, 2014 . Fair Value Measurements June 30, 2015 December 31, 2014 (Level 3) Goodwill $ 549,193 $ 596,620 Goodwill and other identifiable intangible assets with indefinite lives are reviewed for impairment annually, and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Long-lived assets and identifiable intangible assets are also reviewed for impairment whenever events or changes in circumstances indicate that amounts may not be recoverable. If the testing performed indicates that impairment has occurred, the Company will record a noncash impairment charge for the difference between the carrying amount of the goodwill or other intangible assets and the implied fair value of the goodwill or other intangible assets in the period the determination is made. The $47,427 change in the value of Goodwill during the six month period ended June 30, 2015 is the result of exchange rate variance. The table below presents the unrealized gains for the six month periods ended June 30, 2015 and June 30, 2014 . Other income For the six months ended June 30, 2015 June 30, 2014 The net amount of gains for the period included in earnings attributable to the unrealized gain from changes in derivative liabilities at the reporting date $ 4,072,798 $ 2,802,571 Total unrealized gains included in earnings $ 4,072,798 $ 2,802,571 The tables below set forth a summary of changes in fair value of the Company’s Level 3 financial liabilities at fair value for the periods ended June 30, 2015 and December 31, 2014. The tables reflect changes for all financial liabilities at fair value categorized as Level 3 as of June 30, 2015 and December 31, 2014. Level 3 financial liabilities at fair value Net unrealized gains/(losses) Net relating to purchases, Balance, instruments issuances Net transfers Balance, For the six months ended beginning Net realized held at the and in and/or out end of June 30, 2015 of year gains/(losses) reporting date settlements of Level 3 period Derivatives: Conversion feature liability $ (2,944,402 ) $ -0- $ 990,247 $ -0- $ -0- $ (1,954,155 ) Warrant liability (6,695,060 ) -0- 3,082,551 (868,128 ) -0- (4,480,637 ) Total of derivative liabilities $ (9,639,462 ) $ -0- $ 4,072,798 $ (868,128 ) $ -0- $ (6,434,792 ) Level 3 financial liabilities at fair value Net unrealized gains/(losses) Net relating to purchases, Balance, instruments issuances Net transfers Balance, For the year ended beginning Net realized held at the and in and/or out end of December 31, 2014 of year gains/(losses) reporting date settlements of Level 3 year Derivatives: Conversion feature liability $ (3,126,206 ) $ -0- $ 181,804 $ -0- $ -0- $ (2,944,402 ) Warrant liability (5,943,977 ) -0- (122,997 ) (628,086 ) -0- (6,695,060 ) Total of derivative liabilities $ (9,070,183 ) $ -0- $ 58,807 $ (628,086 ) $ -0- $ (9,639,462 )

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 11: COMMITMENTS AND CONTINGENCIES The Company currently leases office space under operating leases for its office locations and has operating leases related to server and network co-location and disaster recovery for its operations. The minimum future lease payments required under the Company’s operating leases at June 30, 2015 are as follows: 2015 $ 360,296 2016 504,222 2017 317,516 2018 244,026 2019 246,450 Thereafter 715,775 Total $ 2,388,285 In addition to annual base rental payments, the Company pays for the operating expenses associated with its leased office space and is responsible for any escalation in operating expenses as determined in the leases. Rent expense was $482,711 and $443,987 for the six month periods ended June 30, 2015 and June 30, 2014, respectively. The Company’s Fort Lauderdale, Florida corporate office lease expires in 2022. The Company’s lease on its New Jersey field office expires in February 2016. The Company currently operates its wholly-owned subsidiary, OmniComm Ltd., in the United Kingdom under the terms of a lease that expires in September 2017. The Company currently operates its wholly-owned subsidiary, OmniComm Europe, GmbH, in Germany under the terms of a lease that expires in July 2016. The Company currently operates its wholly-owned subsidiary, OmniComm Promasys B.V, in the Netherlands under the terms of a lease that expires in October 2018. LEGAL PROCEEDINGS From time to time the Company may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of June 30, 2015, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations. PATENT LITIGATION SETTLEMENT On April 9, 2009, we entered into a Settlement and License Agreement with DataSci, LLC (“DataSci”) . DataSci granted us a worldwide, non-exclusive non-transferable right and license under the Licensed Patent and the right to sublicense TrialMaster on a Technology Transfer and Technology Transition basis. Under the terms of the license, we are obligated to pay royalties quarterly for sales of Licensed Products, as defined therein, from January 1, 2009 until the expiration of the Licensed Patent equal to two percent (2%) of OmniComm’s annual Gross Revenues or, alternatively, the annual minimum royalty payment(s), whichever is greater. The remaining minimum royalty payments per year are as follows: 2015 $ 337,500 2016 450,000 2017 450,000 Total $ 1,237,500 During the six month periods ended June 30, 2015 and June 30, 2014 the Company recorded a charge to earnings of $64,822 and $82,684 respectively, which amounts represent (i) the amount of additional license expense incurred above the stipulated minimum in the DataSci License Agreement during the six month periods ended June 30, 2015 and June 30, 2014 and (ii) the accretion of the difference between the total stipulated annual minimum royalty payments and the recorded present value accrual of the annual minimum royalty payments. EMPLOYMENT AGREEMENTS We have employment agreements in place with the following members of our executive management team: Cornelis F. Wit, Chief Executive Officer Randall G. Smith, Chief Technology Officer Stephen E. Johnson, President and Chief Operating Officer The employment agreements provide, among other things, for participation in employee benefits available to employees and executives. Each of the agreements will renew for successive one-year terms unless the agreement is expressly cancelled by either the employee or the Company ninety days prior to the end of the term. Under the terms of the agreement, we may terminate the employee’s employment upon 30 days notice of a material breach and the employee may terminate the agreement under the same terms and conditions. The employment agreements contain non-disclosure and severance provisions, as well as non-compete clauses.

Note 12 - Related Party Transac

Note 12 - Related Party Transactions	6 Months Ended
	Jun. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 12: RELATED PARTY TRANSACTIONS On May 1, 2015 the Company paid $5,000 to our Chairman and Chief Technology Officer , Randall G. Smith in exchange for an outstanding convertible note in the same amount. The note carried an interest rate of 12% and had a maturity date of January 1, 2016. On April 21, 2014, our Director, Guus van Kesteren, extended the maturity date of his $150,000 of convertible debentures to April 1, 2016. The debentures bear an interest rate of 10% per annum. The convertible debentures were originally issued in August 2008. The expiration date of the warrants associated with the debentures was also extended to April 1, 2016. On July 31, 2014 Mr. van Kesteren’s term on the Board of Directors ended. Effective on the same date, his convertible note in the amount of $150,000 was reclassified from Related Party to Non-Related Party. As of June 30, 2015, we have an aggregate of $15,704 ,000 principal amount of convertible debentures and promissory notes outstanding to Cornelis F. Wit, our Chief Executive Officer and Director, and have issued certain warrants to Mr. Wit, as follows: ● In June 2008, Mr. Wit invested $510,000 in convertible notes. On August 29, 2008, Mr. Wit converted the $510,000 and invested an additional $1,260,000 in a private placement of convertible debentures and warrants to purchase 3,540,000 shares of our common stock. The convertible debentures, which bear interest at 10% per annum, were due on August 29, 2010. The convertible debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.50 per share. On September 30, 2009, the Company and Mr. Wit extended the $1,770,000 of convertible debentures until August 29, 2013 in accordance with the terms of a Secured Convertible Debenture issued on that date. On February 22, 2013, the Company and Mr. Wit extended the maturity date of the $1,770,000 of convertible debentures to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On January 31, 2015 the Company and Mr. Wit extended the maturity date of the $1,770,000 of convertible debentures to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017. ● In February 2008, Mr. Wit invested $150,000 in promissory notes and from September 2008 to December 2008, Mr. Wit invested $4,200,000 in convertible notes. On December 16, 2008, Mr. Wit converted the $4,350,000 into a private placement of convertible debentures and warrants to purchase 8,700,000 shares of our common stock. The convertible debentures, which bear interest at 12% per annum, were due on December 16, 2010. The convertible debentures are convertible at any time at the option of the holder into shares of our common stock based upon a conversion rate of $0.50 per share. On September 30, 2009, the Company and Mr. Wit extended the $4,350,000 of convertible debentures until December 16, 2013 in accordance with the terms of a Secured Convertible Debenture issued on that date. In a private transaction on October 16, 2012, Mr. Wit purchased $125,000 of the December 2008 convertible debentures and the related 250,000 warrants from Mr. Ronald Linares, the Company’s former Chief Financial Officer. On February 22, 2013, the Company and Mr. Wit extended the maturity date of the $4,475,000 of convertible debentures to January 1, 2016. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. As part of Amendment Number Two to Securities Purchase Agreement, Mr. Wit agreed to waive his rights to the granted Security Interest and for the release of the Collateral. On January 31, 2015 the Company and Mr. Wit extended the maturity date of the $4,475,000 of convertible debentures to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017. ● From July 2009 to September 2009, Mr. Wit invested $1,100,000 which amount was aggregated under the terms of one convertible note dated September 30, 2009. On September 30, 2009, Mr. Wit agreed to convert this convertible note into a private placement of secured convertible debentures bearing interest at a rate of 12% per annum with a maturity date of March 30, 2011. The convertible debentures were convertible into 4,400,000 shares of common stock and Mr. Wit received 4,400,000 warrants to purchase common stock of the Company at a price of $0.25. On March 30, 2011, the Company and Mr. Wit extended the maturity date of his convertible note until April 1, 2013 in accordance with the terms of Amendment Number One To Securities Purchase Agreement. The Company also extended the expiration date of the 4,400,000 warrants issued with convertible note by two years to September 30, 2015. On February 22, 2013, the Company and Mr. Wit extended the maturity date of his convertible debentures to January 1, 2016 in accordance with the terms of Amendment Number Two To Securities Purchase Agreement. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On January 31, 2015 the Company and Mr. Wit extended the maturity date of the $1,100,000 of convertible debentures to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017. ● From October 2009 to December 2009, Mr. Wit invested $1,440,000, which amount was aggregated under the terms of one convertible note dated December 31, 2009. On December 31, 2009, Mr. Wit agreed to convert this Convertible Note into a private placement of unsecured convertible debentures bearing interest at a rate of 12% per annum, which Convertible Debentures were due on June 30, 2011. The Company and Mr. Wit extended the maturity date of his convertible note until October 1, 2013 in accordance with the terms of Amendment Number One To Securities Purchase Agreement. The Company also extended the expiration date of the 5,760,000 warrants issued with convertible note by two years to December 31, 2015. On February 22, 2013, the Company and Mr. Wit extended the maturity date of his convertible debentures to January 1, 2016 in accordance with the terms of Amendment Number Two To Securities Purchase Agreement. The expiration date of the warrants associated with the debentures was also extended to January 1, 2016. On January 31, 2015 the Company and Mr. Wit extended the maturity date of the $1,440,000 of convertible debentures to April 1, 2017. The expiration date of the warrants associated with the debentures was also extended to April 1, 2017. ● On March 31, 2011, the Company issued a note payable in the principal amount of $2,866,879 and warrants to purchase 11,467,517 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of March 31, 2016 to Mr. Wit. The note accrues interest at a rate of 12% per annum and had a maturity date of April 1, 2014. The Promissory Note replaced the following Promissory Notes that had been previously issued: i. Promissory Note issued on April 13, 2010 for $450,000 with a maturity date of December 31, 2011; ii. Promissory Note issued on June 29, 2010 for $115,000 with a maturity date of December 31, 2011; iii. Promissory Note issued on September 30, 2010 for $695,000 with a maturity date of December 31, 2011; iv. Promissory Note issued on December 31, 2010 for $1,197,500 with a maturity date of December 31, 2011; and v. Promissory Note issued on December 31, 2010 for $409,379 with a maturity date of April 01, 2012. On April 1, 2013, the Company and Mr. Wit extended the maturity date of the promissory note to March 31, 2016. In December 2014, the outstanding principal was reduced by $6,879. On January 31, 2015 the Company and Mr. Wit extended the maturity date of the $2,860,000 promissory note to April 1, 2017. The expiration date of the warrants associated with the $2,860,000 promissory note was also extended to April 1, 2017. ● On December 31, 2011, the Company issued a promissory note in the principal amount of $1,600,000 and warrants to purchase 6,400,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of December 31, 2015 to Mr. Wit. The note carries an interest rate of 12% per annum and had a maturity date of January 1, 2015. On April 4, 2014, the Company and Mr. Wit extended the maturity date of the promissory note until April 1, 2017. The expiration date of the warrants associated with the promissory note was also extended to April 1, 2017. The promissory note consolidates the amounts owed as detailed below: i. Promissory Note issued on May 13, 2011 for $96,000 with a maturity date of January 01, 2013; ii. Promissory Note issued on September 30, 2011 for $342,000 with a maturity date of April 01, 2014; iii. Promissory Note issued on October 05, 2011 for $130,000 with a maturity date of April 01, 2014; iv. Promissory Note issued on October 28, 2011 for $123,000 with a maturity date of April 01, 2014; v. Promissory Note issued on October 31, 2011 for $82,000 with a maturity date of April 01, 2014; vi. Promissory Note issued on November 23, 2011 for $60,000 with a maturity date of January 1, 2013; and vii. Accrued and unpaid interest in the amount of $767,000. ● On January 1, 2013, the Company issued a promissory note in the principal amount of $529,000 and warrants to purchase 2,116,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of January 31, 2016 to Mr. Wit. The note carries an interest rate of 12% per annum and had a maturity date of January 1, 2016. On January 31, 2015 the Company and Mr. Wit extended the maturity date of the promissory note until April 1, 2017. The expiration date of the warrants associated with the promissory note was also extended to April 1, 2017. ● On January 1, 2014, the Company issued a promissory note in the principal amount of $980,000 and warrants to purchase 3,920,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of April 1, 2017 to Mr. Wit in exchange for accrued interest in the amount of $980,000. The note carries an interest rate of 12% per annum and is due on April 1, 2017. ● On December 23, 2014, the Company issued a promissory note in the principal amount of $280,000 to Mr. Wit. The note carries an interest rate of 12% per annum and is due on April 1, 2017. ● On January 31, 2015, the Company issued a promissory note in the principal amount of $950,000 and warrants to purchase 3,800,000 shares of common stock of the Company at an exercise price of $0.25 per share with an expiration date of April 1, 2017 to Mr. Wit in exchange for an existing promissory note in the amount of $280,000 and accrued interest in the amount of $670,000. The note carries an interest rate of 12% per annum and is due on April 1, 2017. On March 18, 2013, the Company entered into a $2,000,000 revolving line of credit with The Northern Trust Company guaranteed by Cornelis F. Wit, our Chief Executive Officer and Director. On December 18, 2013 the Company renewed the line of credit and increased the available balance to $4,000,000. On February 3, 2015 the Company renewed the line of credit and increased the available balance to $5,000,000. Mr. Wit receives 2.0% interest on the assets pledged for the line of credit. The line of credit matures on February 2, 2018 and carries a variable interest rate based on the prime rate. At June 30, 2015, $5,000,000 was outstanding on the line of credit at an interest rate of 2.25%. For the six month periods ended June 30, 2015 and June 30, 2014 we incurred $1,299,785 and $1,240,176, respectively, in interest expense payable to related parties.

Note 13 - Stockholders' (Defici

Note 13 - Stockholders' (Deficit)	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 13: STOCKHOLDERS’ (DEFICIT) Our authorized capital stock consists of 250,000,000 shares of common stock, $.001 par value per share, and 10,000,000 shares of preferred stock, par value $.001 per share, of which 5,000,000 shares have been designated as 5% Series A Preferred Stock, 230,000 shares have been designated as Series B Preferred Stock, 747,500 shares have been designated as Series C Preferred Stock and 250,000 shares have been designated as Series D Preferred Stock. As of June 30, 2015 we had the following outstanding securities: o 92,845,102 shares of common stock issued and outstanding; o 52 ,263,517 warrants issued and outstanding to purchase shares of our common stock; o 4,125,224 shares of our Series A Preferred Stock issued and outstanding; o -0- shares of our Series B Preferred Stock issued and outstanding; o -0- shares of our Series C Preferred Stock issued and outstanding; o 250,000 share of our Series D Preferred Stock issued and outstanding; and o $9,66 0,000 principal amount Convertible Debentures convertible into 24,61 0,000 shares of common stock. Common Stock Holders of common stock are entitled to one vote for each share on all matters submitted to a stockholder vote. Holders of our voting securities do not have cumulative voting rights. Holders of common stock are entitled to share in all dividends that the Board of Directors, in its discretion, declares from legally available funds. In the event of our liquidation, dissolution or winding up, subject to the preferences of the Series A Preferred Stockholders, each outstanding share of common stock entitles its holder to participate in all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over the common stock. Holders of common stock have no conversion, preemptive or other subscription rights, and there are no redemption provisions for the common stock. The rights of the holders of common stock are subject to any rights that may be fixed for holders of preferred stock, when and if any preferred stock is outstanding. All outstanding shares of common stock are duly authorized, validly issued, fully paid and non-assessable. On July 31, 2014 we issued 1,400,000 restricted shares of our common stock to our senior management team and our Board of Directors under the 2009 Equity Incentive Plan of OmniComm Systems, Inc. (the “2009 Plan”). The restrictions on the shares lapse ratably over a 3 year period. On October 31, 2014 a former director exercised stock options granted to the director during their term. As a result of the exercise, 57,143 common shares were issued to the individual. On March 20, 2015 we issued 665,000 restricted shares of our common stock to our senior management team under the 2009 Plan. The restrictions on the shares lapse ratably over a 3 year period. On March 31, 2015 a former employee exercised stock options granted to the employee during their employment. As a result of the exercise, 7,500 common shares were issued to the individual. On April 29, 2015 an employee exercised stock options granted to the employee during their employment. As a result of the exercise, 5,800 common shares were issued to the individual. On June 11, 2015 we issued 360,000 restricted shares of our common stock to our Board of Directors under the 2009 Plan. The restrictions on the shares lapse ratably over a 3 year period. On June 15, 2015 an employee exercised stock options granted to the employee during their employment. As a result of the exercise, 225,000 common shares were issued to the individual. On June 30, 2015 a former employee exercised stock options granted to the employee during their employment. As a result of the exercise, 20,000 common shares were issued to the individual. The 2009 Plan is more fully described in “Note 14, Employee Equity Incentive Plans”. Preferred S tock Our Board of Directors, without further stockholder approval, may issue preferred stock in one or more series from time to time and fix or alter the designations, relative rights, priorities, preferences, qualifications, limitations and restrictions of the shares of each series. In addition, the Board of Directors may fix and determine all privileges and rights of the authorized preferred stock series including: o dividend and liquidation preferences; o voting rights; o conversion privileges; and o redemption terms . Our Board of Directors may authorize the issuance of preferred stock which ranks senior to our common stock for the payment of dividends and the distribution of assets on liquidation. In addition, our Board of Directors can fix limitations and restrictions, if any, upon the payment of dividends on our common stock to be effective while any shares of preferred stock are outstanding. The following table presents the cumulative arrearage of undeclared dividends by class of preferred stock as of June 30, 2015 and June 30, 2014, respectively, and the per share amount by class of preferred stock. Cumulative arrearage Cumulative arrearage per share as of as of Series of preferred stock 2015 2014 2015 2014 Series A $ 2,688,984 $ 2,482,722 $ 0.65 $ 0.60 Series B 609,887 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 4,770,964 $ 4,564,702 The following table presents preferred dividends accreted for the six month periods ended June 30, 2015 and June 30, 2014, respectively, and the per share effect of the preferred dividends if their effect was not anti-dilutive. Dividends accreted Dividends per share For the six months ended For the six months ended June 30, June 30, 2015 2014 2015 2014 Preferred stock dividends in arrears Series A $ 102,283 $ 102,283 $ 0.025 $ 0.025 Preferred stock dividends in arrears Series B $ -0- $ -0- $ -0- $ -0- Preferred stock dividends in arrears Series C $ -0- $ -0- $ -0- $ -0- Warrants Issued for Services and in Capital Transactions The following tables summarize all outstanding warrants for the periods ended June 30, 2015 and December 31, 2014, and the related changes during these periods. June 30, 2015 June 30, 2015 Warrants outstanding Warrants exercisable Number outstanding Weighted average Weighted average Number exercisable Weighted average Range of exercise price at 2015 remaining contractual life exercise price at 2015 exercise price $0.25 – $0.60 52,263,517 1.78 $ 0.34 52,263,517 $ 0.34 December 31, 2014 December 31, 2014 Warrants outstanding Warrants exercisable Number outstanding Weighted average Weighted average Number exercisable Weighted average Range of exercise price at remaining contractual life exercise price at exercise price $0.25 – $0.60 48,463,517 1.17 $ 0.35 48,463,517 $ 0.35 Warrants Balance at December 31, 2013 44,728,873 Issued 3,920,000 Exercised -0- Expired/forfeited (185,356 ) Balance at December 31, 2014 48,463,517 Issued 3,800,000 Exercised -0- Expired/forfeited -0- Balance at June 30, 2015 52,263,517 Warrants exercisable at June 30, 2015 52,263,517 Weighted average fair value of warrants granted during 2014 $ 0.10 Weighted average fair value of warrants granted during 2015 $ 0.10 Other Comprehensive (Loss) Due to the availability of net operating losses and related deferred tax valuations, there is no tax effect associated with any component of other comprehensive (loss). The following table lists the beginning balance, activity and ending balance of the components of accumulated other comprehensive (loss). Foreign currency translation Accumulated other comprehensive (loss) Balance at December 31, 2013 $ (87,604 ) $ (87,604 ) 2014 Activity (156,223 ) (156,223 ) Balance at December 31, 2014 (243,827 ) (243,827 ) 2015 Activity (83,531 ) (83,531 ) Balance at June 30, 2015 $ (327,358 ) $ (327,358 )

Note 14 - Employee Equity Incen

Note 14 - Employee Equity Incentive Plans	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 14: EMPLOYEE EQUITY INCENTIVE PLANS Stock Option Plan Description of 2009 Equity Incentive Plan In 2009, the Company’s Board of Directors and shareholders approved the 2009 Equity Incentive Plan of OmniComm Systems, Inc. (the “2009 Plan”). The 2009 Plan provides for granting Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Phantom Stock Unit Awards and Performance Share Units. Pursuant to the 2009 Plan, 7,500,000 shares of the Company’s common stock are authorized for issuance. The maximum term for any option grant under the 2009 Plan is ten years from the date of the grant; however, options granted under the 2009 Plan will generally expire five years from the date of grant. Options granted to employees generally vest either upon grant or in two installments. The first vesting, which is equal to 50% of the granted stock options, occurs upon completion of one full year of employment from the date of grant and the second vesting occurs on the second anniversary of the date of grant. The vesting period typically begins on the date of hire for new employees and on the date of grant for existing employees. The restrictions on restricted shares granted to employees generally lapse in three equal annual installments on the anniversary of the date of grant. Any unvested stock options or restricted shares with restrictions that have not lapsed that are granted under the 2009 Plan are forfeited and expire upon termination of employment. As of June 30, 2015, there were 2,517,500 outstanding options and 3 ,650,000 restricted stock shares that have been granted under the 2009 Plan. At June 30, 2015, there were 931,057 shares available for grant as options or other forms of share-based compensation under the 2009 Plan. Description of 1998 Stock Incentive Plan In 1998, the Company’s Board of Directors and shareholders approved the 1998 Stock Incentive Plan of OmniComm Systems, Inc. (the “1998 Plan”). The 1998 Plan provides for granting Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Phantom Stock Unit Awards and Performance Share Units. Pursuant to the 1998 Plan, 12,500,000 shares of the Company’s common stock were authorized for issuance. The 1998 Plan expired as of December 31, 2008. As of June 30, 2015, there were 450,000 outstanding options that have been granted under the 1998 Plan. The following table summarizes the stock option activity for the Company’s equity incentive plans: Number of shares Weighted average exercise price (per share) Weighted average remaining contractual term (in years) Aggregate intrinsic value Outstanding at December 31, 2013 5,745,000 $ 0.29 1.70 $ 93,945 Granted 150,000 0.16 Exercised (150,000 ) 0.13 Forfeited/cancelled/expired (2,615,000 ) 0.40 Outstanding at December 31, 2014 3,130,000 0.20 1.59 $ 364,900 Granted 175,000 0.27 Exercised (282,500 ) 0.12 Forfeited/cancelled/expired (505,000 ) 0.25 Outstanding at June 30, 2015 2,517,500 $ 0.21 1.59 $ 125,800 Vested and exercisable at June 30, 2015 2,192,500 $ 0.21 1.20 $ 120,750 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company’s closing stock price at quarter-end and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on June 30, 2015. The total number of shares vesting and the fair value of shares vesting for the six month periods ended June 30, 2015 and June 30, 2014, respectively, was: Fair value of options vesting Number of options vested Fair value of options vested For the six months ended 125,000 $ 22,235 For the six months ended 433,334 $ 50,845 Cash received from stock option exercises for the six month periods ended June 30, 2015 and June 30, 2014 was $27,250 and $-0-, respectively. Due to the Company’s net loss position, no income tax benefit has been realized during the six month periods ended June 30, 2015 and June 30, 2014. The following table summarizes information concerning options outstanding at June 30, 2015: Awards breakdown by price range at June 30, 2015 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 1,792,500 1.57 $ 0.13 1,642,500 1.37 $ 0.13 0.21 to 0.29 175,000 3.75 0.22 100,000 2.97 0.21 0.30 to 0.49 100,000 4.68 0.30 -0- 0.00 0.00 0.50 to 0.70 450,000 0.18 0.50 450,000 0.18 0.50 0.00 to 0.70 2,517,500 1.59 $ 0.21 2,192,500 1.20 $ 0.21 The following table summarizes information concerning options outstanding at December 31, 2014: Awards breakdown by price range at December 31, 2014 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 2,080,000 1.98 $ 0.13 1,855,000 1.72 $ 0.12 0.21 to 0.29 600,000 0.92 0.24 550,000 0.69 0.25 0.30 to 0.49 -0- 0.00 0.00 -0- 0.00 0.00 0.50 to 0.70 450,000 0.68 0.50 450,000 0.68 0.50 0.00 to 0.70 3,130,000 1.59 $ 0.20 2,855,000 1.35 $ 0.21 The weighted average fair value (per share) of options granted during the six month period ended June 30, 2015 was $0.26 and $0.16 during the six month period ended June 30, 2014. The Black Scholes option-pricing model was utilized to calculate these values. Basis for Fair Value Estimate of Share-Based Payments Based on analysis of its historical volatility, the Company expects that the future volatility of its share price is likely to be similar to the historical volatility the Company experienced since the Company’s commercialization activities were initiated during the second half of 2000. The Company used a volatility calculation utilizing the Company’s own historical volatility to estimate its future volatility for purposes of valuing the share-based payments that have been granted. Actual volatility, and future changes in estimated volatility, may differ substantially from the Company’s current estimates. The Company utilizes the historical data available regarding employee and director exercise activity to calculate an expected life of the options. The table below presents the weighted average expected life in years of options granted under the Plan as described above. The risk-free rate of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant, which corresponds with the expected term of the option granted. Below are the assumptions for the fair value of share-based payments for the six month periods ended June 30, 2015 and June 30, 2014. Stock option assumptions for the period ended Stock option assumptions June 30, 2015 December 31, 2014 Risk-free interest rate 0.98% 0.93% Expected dividend yield 0.0% 0.0% Expected volatility 192.2% 199.0% Expected life of options (in years) 5 5 The following table summarizes weighted average grant date fair value activity for the Company’s incentive stock plans: Weighted average grant date fair value For the six months ended June 30, 2015 2014 Stock options granted during the period $ 0.26 $ 0.16 Stock options vested during the period $ 0.18 $ 0.12 Stock options forfeited during the period $ 0.25 $ 0.44 A summary of the status of the Company’s non-vested shares underlying stock options as of June 30, 2015, and changes during the six month period ended June 30, 2015 is as follows: Shares underlying stock options Weighted average grant date fair value Nonvested shares at January 1, 2015 275,000 $ 0.17 Nonvested shares at June 30, 2015 325,000 $ 0.22 As of June 30, 2015, approximately $51,910 of total unrecognized compensation cost related to unvested stock options is expected to be recognized over a weighted-average period of 1.4 years.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION The Company’s accounts include those of all its wholly-owned subsidiaries, which are more fully described in the Company’s 2014 Annual Report filed on Form 10-K with the Securities and Exchange Commission, and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation.
Consolidation, Policy [Policy Text Block]	UNAUDITED FINANCIAL STATEMENTS The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to such rules and regulations, certain financial information and footnote disclosures normally included in the consolidated financial statements have been condensed or omitted. The results for the periods indicated are unaudited, but reflect all adjustments (consisting only of normally recurring adjustments) which management considers necessary for a fair presentation of operating results. The operating results for the six month period ended June 30, 2015 are not necessarily indicative of the results that may be expected for the year-ended December 31, 2015. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year-ended December 31, 2014.
Use of Estimates, Policy [Policy Text Block]	ESTIMATES IN FINANCIAL STATEMENTS The preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Significant estimates incorporated in our financial statements include the recorded allowance for doubtful accounts, the estimate of the appropriate amortization period of our intangible assets, the evaluation of whether our intangible assets have suffered any impairment, the allocation of revenues under multiple-element customer contracts, royalty-based patent liabilities, the value of derivatives associated with debt issued by the Company and the valuation of any corresponding discount to the issuance of our debt. Actual results may differ from those estimates.
Reclassification, Policy [Policy Text Block]	Reclassifications Certain reclassifications have been made in the 2014 financial statements to conform to the 2015 presentation. These reclassifications did not have any effect on our net income/(loss) or shareholders’ deficit.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	foreign currency translation The financial statements of the Company’s foreign subsidiaries are translated in accordance with Accounting Standards Codification (“ASC”) 830-30, Foreign Currency Matters—Translation of Financial Statements
Revenue Recognition, Policy [Policy Text Block]	REVENUE RECOGNITION POLICY The Company derives revenues from software licenses and services of its EDC products and services which can be purchased on a stand-alone basis. License revenues are derived principally from the sale of term licenses for the following software products offered by the Company: TrialMaster, TrialOne , eClinical Suite Promasys . TrialMaster eClinical Suite The Company recognizes revenues when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) the product or service has been provided to the customer; (3) the collection of fees is probable; and (4) the amount of fees to be paid by the customer is fixed or determinable. The Company operates in one reportable segment which is the delivery of EDC Software and services to clinical trial sponsors. The Company segregates its revenues based on the activity cycle used to generate its revenues. Accordingly, revenues are currently generated through four main activities , including hosted applications, licensing, professional services and maintenance-related services. Hosted Application Revenues The Company offers its TrialMaster eClinical Suite TrialOne Promasys TrialMaster eClinical Suite Revenues resulting from TrialMaster eClinical Suite Fees charged for the trial system design, set up and implementation are amortized and recognized ratably over the estimated hosting period. Work performed outside the original scope of work is contracted for separately as an additional fee and is generally recognized ratably over the remaining term of the hosting period. Fees for the first and third stages of the service are typically billed based upon milestones. Revenues earned upon completion of a contractual milestone are deferred and recognized over the estimated remaining hosting period. Fees for application hosting and related services in the second stage are generally billed monthly or quarterly in advance. Revenues resulting from hosting services for the eClinical Suite Licensing Revenues The Company's software license revenues are earned from the sale of off-the-shelf software. From time-to-time a client might require significant modification or customization subsequent to delivery to the customer. The Company generally enters into software term licenses for its EDC Software products with its customers for three to five year periods, although customers have entered into both longer and shorter term license agreements. These arrangements typically include multiple elements: software license, consulting services and customer support. The Company bills its customers in accordance with the terms of the underlying contract. Generally, the Company bills license fees in advance for each billing cycle of the license term, which typically is either on a quarterly or annual basis. Payment terms are generally net 30 days. In the past the Company has sold perpetual licenses for EDC Software products in certain situations to existing customers with the option to purchase customer support, and may, in the future, do so for new customers based on customer requirements or market conditions. The Company has established vendor specific objective evidence of fair value for the customer support. Accordingly, license revenues are recognized upon delivery of the software and when all other revenue recognition criteria are met. Customer support revenues are recognized ratably over the term of the underlying support arrangement. The Company generates customer support and maintenance revenues from its perpetual license customer base. Professional Services The Company may also enter into arrangements to provide consulting services separate from a license arrangement. In these situations, revenue is recognized on a time-and-materials basis. Professional services can be deemed to be as essential to the functionality of the software at inception and typically are for initial trial configuration, implementation planning, loading of software, building simple interfaces, running test data and documentation of procedures. Subsequent additions or extensions to license terms do not generally include additional professional services. Pass-through Revenue and Expense The Company accounts for pass-through revenue and expense in accordance with ASC 605-45, Principal Agent Considerations Maintenance Revenues Maintenance includes telephone-based help desk support and software maintenance. The Company generally bundles customer support with the software license for the entire term of the arrangement. As a result, the Company generally recognizes revenues for both maintenance and software licenses ratably over the term of the software license and support arrangement. The Company allocates the revenues recognized for these arrangements to the different elements based on management's estimate of the relative fair value of each element. The Company generally invoices each of the elements based on separately quoted amounts and thus has a fairly accurate estimate of the relative fair values of each of the invoiced revenue elements. The fees associated with each business activity for the periods ended June 30, 2015 and June 30, 2014, respectively are: For the six months ended June 30, 2015 June 30, 2014 Revenue activity Set-up fees $ 2,882,153 $ 1,943,854 Change orders 354,808 196,954 Maintenance 2,501,407 2,011,646 Software licenses 1,527,374 1,286,147 Professional services 1,924,967 952,805 Hosting 482,317 399,618 Total $ 9,673,026 $ 6,791,024 For the three months ended June 30, 2015 June 30, 2014 Revenue activity Set-up fees $ 1,617,609 $ 1,136,021 Change orders 212,767 83,866 Maintenance 1,269,530 1,052,015 Software licenses 786,437 618,830 Professional services 707,970 508,298 Hosting 240,586 209,719 Total $ 4,834,899 $ 3,608,749
Cost of Sales, Policy [Policy Text Block]	COST OF REVENUES Cost of revenues primarily consists of costs related to hosting, maintaining and supporting the Company’s application suite and delivering professional services and support. These costs include salaries, benefits, and bonuses for the Company’s professional services staff. Cost of revenues also includes outside service provider costs .
Cash and Cash Equivalents, Policy [Policy Text Block]	CASH AND CASH EQUIVALENTS Cash equivalents consist of highly liquid, short-term investments with maturities of 90 days or less. The carrying amount reported in the accompanying consolidated balance sheets approximates fair value.
Receivables, Policy [Policy Text Block]	ACCOUNTS RECEIVABLE Accounts receivable are judged as to collectability by management and an allowance for bad debts is established as necessary. The allowance is based on an evaluation of the collectability of accounts receivable and prior bad debt experience. The Company had recorded an allowance for uncollectible accounts receivable of $99,083 as of June 30, 2015 and $186,085 as of December 31, 2014, respectively. The following table summarizes activity in the Company's allowance for doubtful accounts for the periods presented. June 30, 2015 December 31, 2014 Beginning of period $ 186,085 $ 65,341 Bad debt expense (5,402 ) 147,543 Write-offs (81,600 ) (26,875 ) Exchange rate impact -0- 76 End of period $ 99,083 $ 186,085
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Credit Risk Cash and cash equivalents and restricted cash are deposited with major financial institutions and, at times, such balances with any one financial institution may be in excess of FDIC-insured limits. As of June 30, 2015, $795,717 was deposited in excess of FDIC-insured limits. Management believes the risk in these situations to be minimal. Except as follows, the Company has no significant off-balance-sheet risk or credit risk concentrations. Financial instruments that subject the Company to potential credit risks are principally cash equivalents and accounts receivable. Concentrated credit risk with respect to accounts receivable is limited to creditworthy customers. The Company's customers are principally located in the United States , Europe and East Asia. The Company is directly affected by the overall financial condition of the pharmaceutical, biotechnology and medical device industries and management believes that credit risk exists and that any credit risk the Company faces has been adequately reserved for as of June 30, 2015. The Company maintains an allowance for doubtful accounts based on accounts past due according to contractual terms and historical collection experience. Actual losses , when incurred , are charged to the allowance. The Company's losses related to collection of accounts receivable have consistently been within management's expectations. As of June 30, 2015, the Company believes no additional credit risk exists beyond the amounts provided for in our allowance for uncollectible accounts. The Company evaluates its allowance for uncollectable accounts on a quarterly basis based on a specific review of receivable aging and the period that any receivables are beyond the standard payment terms. The Company does not require collateral from its customers in order to mitigate credit risk. One customer accounted for 13% of our revenues during the six month period ended June 30, 2015 or approximately $1,249,000. One customer accounted for 13% of our revenues during the six month period ended June 30, 2014 or approximately $856,000. The following table summarizes the number of customers who individually comprise greater than 10% of total revenue and/or total accounts receivable and their aggregate percentage of the Company's total revenue and gross accounts receivable for the periods presented. Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable June 30, 2015 1 13% 2 31% December 31, 2014 1 15% 1 18% June 30, 2014 1 13% 2 32% The table below provides revenues from European customers for the six month periods ended June 30, 2015 and June 30, 2014, respectively. European revenues For the six months ended June 30, 2015 June 30, 2014 European revenues % of Total revenues European revenues % of Total revenues $ 1,084,178 11% $ 1,296,534 19% The Company serves all of its hosting customers from third-party web hosting facilities located in the United States. The Company does not control the operation of these facilities, and they are vulnerable to damage or interruption. The Company maintains redundant systems that can be used to provide service in the event the third-party web hosting facilities become unavailable, although in such circumstances, the Company's service may be interrupted during the transition.
Property, Plant and Equipment, Policy [Policy Text Block]	PROPERTY AND EQUIPMENT Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is calculated using the straight-line method over the asset’s estimated useful life, which is 5 years for leasehold improvements, computers, equipment and furniture and 3 years for software. Gains or losses on disposal are charged to operations.
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	ASSET IMPAIRMENT Acquisitions and Intangible Assets We account for acquisitions in accordance with ASC 805, Business Combinations ASC 350, Intangibles- Goodwill and Other The judgments that we make in determining the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact net income in periods following an asset acquisition. We generally use either the income, cost or market approach to aid in our conclusions of such fair values and asset lives. The income approach presumes that the value of an asset can be estimated by the net economic benefit to be received over the life of the asset, discounted to present value. The cost approach presumes that an investor would pay no more for an asset than its replacement or reproduction cost. The market approach estimates value based on what other participants in the market have paid for reasonably similar assets. Although each valuation approach is considered in valuing the assets acquired, the approach ultimately selected is based on the characteristics of the asset and the availability of information. Long-lived Assets We review long-lived assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment has occurred typically requires various estimates and assumptions, including determining which cash flows are directly related to the potentially impaired asset, the useful life over which cash flows will occur, their amount and the asset’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. We use quoted market prices when available and independent appraisals and management estimates of future operating cash flows, as appropriate, to determine fair value.
Fair Value of Financial Instruments, Policy [Policy Text Block]	FAIR VALUE MEASUREMENT OmniComm’s capital structure includes the use of warrants and convertible debt features that are classified as derivative financial instruments. Derivative financial instruments are recognized as either assets or liabilities and are measured at fair value under ASC 815 , Derivatives and Hedging . , Fair Value Measurements and Disclosures
Revenue Recognition, Deferred Revenue [Policy Text Block]	DEFERRED REVENUE Deferred revenue represents cash advances and amounts in accounts receivable as of the balance sheet date received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may include an initial payment at the time the contract is executed, with future payments dependent upon the completion of certain contract phases or targeted milestones. In the event of contract cancellation, the Company is generally entitled to payment for all work performed through the point of cancellation. As of June 30, 2015, the Company had $8,563,929 in deferred revenues relating to contracts for services to be performed over periods ranging from one month to 5.8 years. The Company had $6,696,830 in deferred revenues that are expected to be recognized in the next twelve fiscal months.
Advertising Costs, Policy [Policy Text Block]	ADVERTISING Advertising costs are expensed as incurred. Advertising costs were $406,502 and $228,530 for the six month periods ended June 30, 2015 and June 30, 2014, respectively and are included under selling, general and administrative expenses in our unaudited condensed consolidated financial statements.
Research, Development, and Computer Software, Policy [Policy Text Block]	RESEARCH AND DEVELOPMENT EXPENSES Software development costs are included in R&D and are expensed as incurred. ASC 985-20, Software Industry Costs of Software to Be Sold, Leased or Marketed
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	EMPLOYEE EQUITY INCENTIVE PLANS The OmniComm Systems, Inc. 2009 Equity Incentive Plan (the “2009 Plan”) was approved at our Annual Meeting of Shareholders on July 10, 2009. The 2009 Plan provides for the issuance of up to 7,500,000 shares to employees, directors and key consultants. The predecessor plan, the OmniComm Systems, Inc., 1998 Stock Incentive Plan (the “1998 Plan”) expired on December 31, 2008. The 1998 Plan provided for the issuance of up to 12 ,5 00,000 shares in accordance with the terms of the 1998 Plan document. Each plan is more fully described in “Note 14, Employee Equity Incentive Plans”. The Company accounts for its employee equity incentive plans under Compensation – Stock Compensation ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s consolidated statements of operations. The Company currently uses the Black Scholes option pricing model to determine grant date fair value.
Earnings Per Share, Policy [Policy Text Block]	EARNINGS PER SHARE The Company accounts for Earnings per Share using ASC 260, Earnings per Share . Unlike diluted earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities.
Income Tax, Policy [Policy Text Block]	INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, Income Taxes . Valuation allowances are established when necessary to reduce deferred tax assets to the estimated amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities.
New Accounting Pronouncements, Policy [Policy Text Block]	IMPACT OF NEW ACCOUNTING STANDARDS During the first six months of 2015, we adopted the following new accounting pronouncements: In May 2014, FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” consolidated financial statements. In August 2014, FASB issued ASU No. 2014-15, “Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” , (“ASU 2014-15”), which requires management to evaluate, in connection with preparing financial statements for each annual and interim reporting period, whether there are conditions or events, considered in the aggregate, that raise substantial doubt about an entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable) and provide related disclosures. ASU 2014-15 is effective for the annual period ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. We believe the adoption of this guidance will not have a material effect on our consolidated financial statements . Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Note 2 - Summary of Significa23

Note 2 - Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Revenue Recognition, Multiple-deliverable Arrangements [Table Text Block]	For the six months ended June 30, 2015 June 30, 2014 Revenue activity Set-up fees $ 2,882,153 $ 1,943,854 Change orders 354,808 196,954 Maintenance 2,501,407 2,011,646 Software licenses 1,527,374 1,286,147 Professional services 1,924,967 952,805 Hosting 482,317 399,618 Total $ 9,673,026 $ 6,791,024 For the three months ended June 30, 2015 June 30, 2014 Revenue activity Set-up fees $ 1,617,609 $ 1,136,021 Change orders 212,767 83,866 Maintenance 1,269,530 1,052,015 Software licenses 786,437 618,830 Professional services 707,970 508,298 Hosting 240,586 209,719 Total $ 4,834,899 $ 3,608,749
Allowance for Credit Losses on Financing Receivables [Table Text Block]	June 30, 2015 December 31, 2014 Beginning of period $ 186,085 $ 65,341 Bad debt expense (5,402 ) 147,543 Write-offs (81,600 ) (26,875 ) Exchange rate impact -0- 76 End of period $ 99,083 $ 186,085
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Revenues Accounts receivable For the period ended Number of customers Percentage of total revenues Number of customers Percentage of accounts receivable June 30, 2015 1 13% 2 31% December 31, 2014 1 15% 1 18% June 30, 2014 1 13% 2 32%
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	European revenues For the six months ended June 30, 2015 June 30, 2014 European revenues % of Total revenues European revenues % of Total revenues $ 1,084,178 11% $ 1,296,534 19%

Note 4 - Earnings_(Loss) Per 24

Note 4 - Earnings/(Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Anti-dilutive security June 30, 2015 June 30, 2014 Preferred stock 2,750,149 2,750,149 Employee stock options 1,563,793 5,275,000 Warrants 52,263,517 48,463,517 Convertible notes 13,850,000 24,620,000 Shares issuable for accrued interest 875,009 957,661 Total 71,302,468 82,066,327
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	For the six months ended June 30, 2015 June 30, 2014 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 1,821,485 91,999,079 $ 0.02 $ (979,099 ) 90,104,659 $ (0.01 ) Effect of dilutive securities - (387,828 ) 11,713,707 (0.03 ) -0- -0- -0- Diluted EPS $ 1,433,657 103,712,786 $ 0.01 $ (979,099 ) 90,104,659 $ (0.01 ) For the three months ended June 30, 2015 June 30, 2014 Income/(loss) Shares Per-share Income/(loss) Shares Per-share numerator denominator amount numerator denominator amount Basic EPS $ 4,627,529 92,350,506 $ 0.05 $ 580,640 90,104,659 $ 0.01 Effect of dilutive securities - (1,460,161 ) 28,313,856 (0.05 ) -0- 617,447 -0- Diluted EPS $ 3,167,368 120,664,362 $ 0.03 $ 580,640 90,722,106 $ 0.01

Note 5 - Property and Equipme25

Note 5 - Property and Equipment, Net (Tables)	6 Months Ended
	Jun. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	June 30, 2015 December 31, 2014 Cost Accumulated depreciation Net book value Cost Accumulated depreciation Net book value Estimated useful life (years) Computer & office equipment $ 1,903,386 $ 1,546,029 $ 357,357 $ 1,880,183 $ 1,482,737 $ 397,446 5 Leasehold improvements 92,246 84,796 7,450 92,504 82,353 10,151 5 Computer software 1,852,482 1,569,680 282,802 1,580,640 1,528,418 52,222 3 Office furniture 112,034 105,306 6,728 113,365 105,048 8,317 5 Total $ 3,960,148 $ 3,305,811 $ 654,337 $ 3,666,692 $ 3,198,556 $ 468,136

Note 6 - Intangible Assets, a26

Note 6 - Intangible Assets, at Cost (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	June 30, 2015 December 31, 2014 Asset Cost Accumulated amortization Net book value Cost Accumulated amortization Net book value Estimated useful life (years) eClinical customer lists $ 1,392,701 $ 1,392,701 $ -0- $ 1,392,701 $ 1,392,701 $ -0- 3 Promasys B.V. customer lists 110,742 12,305 98,437 120,305 9,357 110,948 15 Promasys B.V. software code 72,837 24,279 48,558 72,837 16,995 55,842 5 Promasys B.V. URLs/Website 55,930 31,072 24,858 60,760 23,629 37,131 3 Total $ 1,632,210 $ 1,460,357 $ 171,853 $ 1,646,603 $ 1,442,682 $ 203,921
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2015 $ 20,297 2016 37,486 2017 21,950 2018 19,522 2019 7,383 Thereafter 65,215 Total $ 171,853

Note 7 - Accounts Payable and27

Note 7 - Accounts Payable and Accrued Expenses (Tables)	6 Months Ended
	Jun. 30, 2015
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Account June 30, 2015 December 31, 2014 Accounts payable $ 823,291 $ 613,584 Accrued payroll and related costs 438,048 319,629 Other accrued expenses 79,159 85,248 Accrued interest 783,692 875,724 Total accounts payable and accrued expenses $ 2,124,190 $ 1,894,185

Note 8 - Line of Credit and N28

Note 8 - Line of Credit and Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	Ending Non related party Related party Origination Maturity Interest principal Long Long date date rate June 30, 2015 Current term Current term 1/1/2014 4/1/2017 12% $ 980,000 $ -0- $ -0- $ -0- $ 980,000 4/4/2014 4/1/2017 12% 1,600,000 -0- -0- -0- 1,600,000 4/4/2014 4/1/2017 12% 45,000 -0- 45,000 -0- -0- 4/4/2014 4/1/2017 12% 137,500 -0- 137,500 -0- -0- 4/4/2014 4/1/2017 10% 120,000 -0- 120,000 -0- -0- 12/1/2014 4/1/2017 10% 300,000 -0- 300,000 -0- -0- 12/1/2014 4/1/2017 12% 90,000 -0- 90,000 -0- -0- 12/1/2014 4/1/2017 12% 100,000 -0- 100,000 -0- -0- 1/31/2015 4/1/2017 12% 2,860,000 -0- -0- -0- 2,860,000 1/31/2015 4/1/2017 12% 529,000 -0- -0- -0- 529,000 1/31/2015 4/1/2017 12% 950,000 -0- -0- -0- 950,000 4/1/2015 4/1/2018 12% 20,000 -0- -0- -0- 20,000 Discount on note payable -0- -0- -0- (1,106,070 ) Total $ 7,731,500 $ -0- $ 792,500 $ -0- $ 5,832,930 Ending principal Non related party Related party Origination Maturity Interest December 31, Long Long date date rate 2014 Current term Current term 1/1/2013 1/1/2016 12% $ 529,000 $ -0- $ -0- $ -0- $ 529,000 2/22/2013 1/1/2016 12% 20,000 -0- -0- -0- 20,000 4/1/2013 3/31/2016 12% 2,860,000 -0- -0- -0- 2,860,000 1/1/2014 4/1/2017 12% 980,000 -0- -0- -0- 980,000 4/4/2014 4/1/2017 12% 1,600,000 -0- -0- -0- 1,600,000 4/4/2014 4/1/2017 12% 45,000 -0- 45,000 -0- -0- 4/4/2014 4/1/2017 12% 137,500 -0- 137,500 -0- -0- 4/4/2014 4/1/2017 10% 120,000 -0- 120,000 -0- -0- 12/1/2014 4/1/2017 10% 300,000 -0- 300,000 -0- -0- 12/1/2014 4/1/2017 12% 90,000 -0- 90,000 -0- -0- 12/1/2014 4/1/2017 12% 100,000 -0- 100,000 -0- -0- 12/17/2014 1/1/2016 12% 20,000 -0- 20,000 -0- -0- 12/23/2014 4/1/2017 12% 280,000 -0- -0- -0- 280,000 Discount on note payable -0- -0- -0- (568,209 ) Total $ 7,081,500 $ -0- $ 812,500 $ -0- $ 5,700,791

Note 9 - Convertible Notes Pa29

Note 9 - Convertible Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2015
Note 9 - Convertible Notes Payable (Tables) [Line Items]
Schedule of Maturities of Long-term Debt [Table Text Block]	2015 $ 75,000 2016 -0- 2017 9,195,000 2018 390,000 Total $ 9,660,000
Convertible Debt [Member]
Note 9 - Convertible Notes Payable (Tables) [Line Items]
Schedule of Long-term Debt Instruments [Table Text Block]	Principal Discount Carrying amount Carrying amount at Total at at Short term Long term Date of Maturity Interest Original June 30, Allocated discount June 30, June 30, Related Non Related Non related 8/1/1999 6/30/2004 10% $ 862,500 $ 75,000 $ -0- $ -0- $ -0- $ 75,000 $ -0- $ 75,000 $ -0- $ -0- 8/29/2008 4/1/2017 10% 150,000 150,000 135,600 135,600 -0- 150,000 -0- -0- -0- 150,000 8/29/2008 4/1/2017 10% 2,120,000 1,770,000 1,916,480 1,916,480 -0- 1,770,000 -0- -0- 1,770,000 -0- 12/16/2008 4/1/2017 12% 260,000 260,000 70,200 70,200 -0- 260,000 -0- -0- -0- 260,000 12/16/2008 4/1/2017 12% 4,570,000 4,475,000 1,233,900 1,233,900 -0- 4,475,000 -0- -0- 4,475,000 -0- 12/16/2008 4/1/2018 12% 215,000 215,000 58,050 58,050 -0- 215,000 -0- -0- -0- 215,000 12/16/2008 4/1/2018 12% 25,000 25,000 6,750 6,750 -0- 25,000 -0- -0- 25,000 -0- 9/30/2009 4/1/2017 12% 1,300,000 1,100,000 488,800 488,800 -0- 1,100,000 -0- -0- 1,100,000 -0- 9/30/2009 4/1/2018 12% 100,000 100,000 37,600 37,600 -0- 100,000 -0- -0- -0- 100,000 12/31/2009 4/1/2017 12% 1,440,000 1,440,000 904,320 904,320 -0- 1,440,000 -0- -0- 1,440,000 -0- 12/31/2009 4/1/2018 12% 50,000 50,000 31,400 31,400 -0- 50,000 -0- -0- -0- 50,000 Total $ 11,092,500 $ 9,660,000 $ 4,883,100 $ 4,883,100 $ -0- $ 9,660,000 $ 0 $ 75,000 $ 8,810,000 $ 775,000 Principal Discount Carrying Carrying amount at Total at amount Short term Long term Date of Maturity Interest Original December Allocated discount December December Related Non related Related Non related 8/1/1999 6/30/2004 10% $ 862,500 $ 75,000 $ -0- $ -0- $ -0- $ 75,000 $ -0- $ 75,000 $ -0- $ -0- 8/29/2008 1/1/2016 10% 2,120,000 1,770,000 1,916,480 1,916,480 -0- 1,770,000 -0- -0- 1,770,000 -0- 8/29/2008 4/1/2016 10% 150,000 150,000 135,600 135,600 -0- 150,000 -0- -0- -0- 150,000 12/16/2008 1/1/2016 12% 375,000 375,000 101,250 101,250 -0- 375,000 -0- -0- -0- 375,000 12/16/2008 1/1/2016 12% 4,600,000 4,505,000 1,242,000 1,242,000 -0- 4,505,000 -0- -0- 4,505,000 -0- 12/16/2008 4/1/2016 12% 100,000 100,000 27,000 27,000 -0- 100,000 -0- -0- -0- 100,000 9/30/2009 1/1/2016 12% 100,000 100,000 37,600 37,600 -0- 100,000 -0- -0- -0- 100,000 9/30/2009 1/1/2016 12% 1,300,000 1,100,000 488,800 488,800 -0- 1,100,000 -0- -0- 1,100,000 -0- 12/31/2009 1/1/2016 12% 50,000 50,000 31,400 31,400 -0- 50,000 -0- -0- -0- 50,000 12/31/2009 1/1/2016 12% 1,440,000 1,440,000 904,320 904,320 -0- 1,440,000 -0- -0- 1,440,000 -0- Total $ 11,097,500 $ 9,665,000 $ 4,884,450 $ 4,884,450 $ -0- $ 9,665,000 $ -0- $ 75,000 $ 8,815,000 $ 775,000

Note 10 - Fair Value Measurem30

Note 10 - Fair Value Measurement (Tables)	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Fair value at Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs June 30, 2015 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 1,954,155 $ -0- $ -0- $ 1,954,155 Warrant liability 4,480,637 -0- -0- 4,480,637 Total of derivative liabilities $ 6,434,792 $ -0- $ -0- $ 6,434,792 Fair value at December 31, Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs 2014 (Level 1) (Level 2) (Level 3) Derivatives: (1) (2) Conversion feature liability $ 2,944,402 $ -0- $ -0- $ 2,944,402 Warrant liability 6,695,060 -0- -0- 6,695,060 Total of derivative liabilities $ 9,639,462 $ -0- $ -0- $ 9,639,462
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	Significant valuation assumptions of derivative instruments at June 30, 2015 Risk free interest rate 0.24% Dividend yield 0.00% Expected volatility 73.8% to 144.0% Expected life (range in years) Conversion feature liability 1.76 to 2.76 Warrant liability 0.51 to 2.76 Significant valuation assumptions of derivative instruments at December 31, 2014 Risk free interest rate 0.13% Dividend yield 0.00% Expected volatility 119.8% to 155.7% Expected life (range in years) Conversion feature liability 1.00 to 1.25 Warrant liability 1.00 to 2.25
Fair Value Measurements, Nonrecurring [Table Text Block]	Carrying amount December 31, Carrying amount Quoted prices in active markets for identical assets/ liabilities Significant other observable inputs Significant unobservable inputs 2014 June 30, 2015 (Level 1) (Level 2) (Level 3) Acquired assets (3) Promasys B.V. customer list (4) $ 110,948 $ 98,437 $ -0- $ -0- $ 136,253 Promasys B.V. software code (4) 55,842 48,558 -0- -0- 72,943 Promasys B.V. URLs/website (4) 37,131 24,858 -0- -0- 68,814 Total $ 203,921 $ 171,853 $ -0- $ -0- $ 278,010
Schedule of Goodwill [Table Text Block]	Fair Value Measurements June 30, 2015 December 31, 2014 (Level 3) Goodwill $ 549,193 $ 596,620
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block]	Other income For the six months ended June 30, 2015 June 30, 2014 The net amount of gains for the period included in earnings attributable to the unrealized gain from changes in derivative liabilities at the reporting date $ 4,072,798 $ 2,802,571 Total unrealized gains included in earnings $ 4,072,798 $ 2,802,571
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	Level 3 financial liabilities at fair value Net unrealized gains/(losses) Net relating to purchases, Balance, instruments issuances Net transfers Balance, For the six months ended beginning Net realized held at the and in and/or out end of June 30, 2015 of year gains/(losses) reporting date settlements of Level 3 period Derivatives: Conversion feature liability $ (2,944,402 ) $ -0- $ 990,247 $ -0- $ -0- $ (1,954,155 ) Warrant liability (6,695,060 ) -0- 3,082,551 (868,128 ) -0- (4,480,637 ) Total of derivative liabilities $ (9,639,462 ) $ -0- $ 4,072,798 $ (868,128 ) $ -0- $ (6,434,792 ) Level 3 financial liabilities at fair value Net unrealized gains/(losses) Net relating to purchases, Balance, instruments issuances Net transfers Balance, For the year ended beginning Net realized held at the and in and/or out end of December 31, 2014 of year gains/(losses) reporting date settlements of Level 3 year Derivatives: Conversion feature liability $ (3,126,206 ) $ -0- $ 181,804 $ -0- $ -0- $ (2,944,402 ) Warrant liability (5,943,977 ) -0- (122,997 ) (628,086 ) -0- (6,695,060 ) Total of derivative liabilities $ (9,070,183 ) $ -0- $ 58,807 $ (628,086 ) $ -0- $ (9,639,462 )

Note 11 - Commitments and Con31

Note 11 - Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Minimum Royalty Payments [Table Text Block]	2015 $ 360,296 2016 504,222 2017 317,516 2018 244,026 2019 246,450 Thereafter 715,775 Total $ 2,388,285
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	2015 $ 337,500 2016 450,000 2017 450,000 Total $ 1,237,500

Note 13 - Stockholders' (Defi32

Note 13 - Stockholders' (Deficit) (Tables)	6 Months Ended
	Jun. 30, 2015
Note 13 - Stockholders' (Deficit) (Tables) [Line Items]
Schedule of Dividends in Arrears [Table Text Block]	Cumulative arrearage Cumulative arrearage per share as of as of Series of preferred stock 2015 2014 2015 2014 Series A $ 2,688,984 $ 2,482,722 $ 0.65 $ 0.60 Series B 609,887 609,887 $ 3.05 $ 3.05 Series C 1,472,093 1,472,093 $ 4.37 $ 4.37 Total preferred stock arrearage $ 4,770,964 $ 4,564,702
Schedule of Dividends Payable [Table Text Block]	Dividends accreted Dividends per share For the six months ended For the six months ended June 30, June 30, 2015 2014 2015 2014 Preferred stock dividends in arrears Series A $ 102,283 $ 102,283 $ 0.025 $ 0.025 Preferred stock dividends in arrears Series B $ -0- $ -0- $ -0- $ -0- Preferred stock dividends in arrears Series C $ -0- $ -0- $ -0- $ -0-
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	June 30, 2015 June 30, 2015 Warrants outstanding Warrants exercisable Number outstanding Weighted average Weighted average Number exercisable Weighted average Range of exercise price at 2015 remaining contractual life exercise price at 2015 exercise price $0.25 – $0.60 52,263,517 1.78 $ 0.34 52,263,517 $ 0.34 December 31, 2014 December 31, 2014 Warrants outstanding Warrants exercisable Number outstanding Weighted average Weighted average Number exercisable Weighted average Range of exercise price at remaining contractual life exercise price at exercise price $0.25 – $0.60 48,463,517 1.17 $ 0.35 48,463,517 $ 0.35
Schedule of Share-based Compensation, Activity [Table Text Block]	Weighted average grant date fair value For the six months ended June 30, 2015 2014 Stock options granted during the period $ 0.26 $ 0.16 Stock options vested during the period $ 0.18 $ 0.12 Stock options forfeited during the period $ 0.25 $ 0.44
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Foreign currency translation Accumulated other comprehensive (loss) Balance at December 31, 2013 $ (87,604 ) $ (87,604 ) 2014 Activity (156,223 ) (156,223 ) Balance at December 31, 2014 (243,827 ) (243,827 ) 2015 Activity (83,531 ) (83,531 ) Balance at June 30, 2015 $ (327,358 ) $ (327,358 )
Warrant [Member]
Note 13 - Stockholders' (Deficit) (Tables) [Line Items]
Schedule of Share-based Compensation, Activity [Table Text Block]	Warrants Balance at December 31, 2013 44,728,873 Issued 3,920,000 Exercised -0- Expired/forfeited (185,356 ) Balance at December 31, 2014 48,463,517 Issued 3,800,000 Exercised -0- Expired/forfeited -0- Balance at June 30, 2015 52,263,517 Warrants exercisable at June 30, 2015 52,263,517 Weighted average fair value of warrants granted during 2014 $ 0.10 Weighted average fair value of warrants granted during 2015 $ 0.10

Note 14 - Employee Equity Inc33

Note 14 - Employee Equity Incentive Plans (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of shares Weighted average exercise price (per share) Weighted average remaining contractual term (in years) Aggregate intrinsic value Outstanding at December 31, 2013 5,745,000 $ 0.29 1.70 $ 93,945 Granted 150,000 0.16 Exercised (150,000 ) 0.13 Forfeited/cancelled/expired (2,615,000 ) 0.40 Outstanding at December 31, 2014 3,130,000 0.20 1.59 $ 364,900 Granted 175,000 0.27 Exercised (282,500 ) 0.12 Forfeited/cancelled/expired (505,000 ) 0.25 Outstanding at June 30, 2015 2,517,500 $ 0.21 1.59 $ 125,800 Vested and exercisable at June 30, 2015 2,192,500 $ 0.21 1.20 $ 120,750
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Fair value of options vesting Number of options vested Fair value of options vested For the six months ended 125,000 $ 22,235 For the six months ended 433,334 $ 50,845
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Awards breakdown by price range at June 30, 2015 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 1,792,500 1.57 $ 0.13 1,642,500 1.37 $ 0.13 0.21 to 0.29 175,000 3.75 0.22 100,000 2.97 0.21 0.30 to 0.49 100,000 4.68 0.30 -0- 0.00 0.00 0.50 to 0.70 450,000 0.18 0.50 450,000 0.18 0.50 0.00 to 0.70 2,517,500 1.59 $ 0.21 2,192,500 1.20 $ 0.21 Awards breakdown by price range at December 31, 2014 Outstanding Vested Strike price range ($) Outstanding stock options Weighted average remaining contractual life Weighted average outstanding strike price Vested stock options Weighted average remaining vested contractual life Weighted average vested strike price 0.00 to 0.20 2,080,000 1.98 $ 0.13 1,855,000 1.72 $ 0.12 0.21 to 0.29 600,000 0.92 0.24 550,000 0.69 0.25 0.30 to 0.49 -0- 0.00 0.00 -0- 0.00 0.00 0.50 to 0.70 450,000 0.68 0.50 450,000 0.68 0.50 0.00 to 0.70 3,130,000 1.59 $ 0.20 2,855,000 1.35 $ 0.21
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Stock option assumptions for the period ended Stock option assumptions June 30, 2015 December 31, 2014 Risk-free interest rate 0.98% 0.93% Expected dividend yield 0.0% 0.0% Expected volatility 192.2% 199.0% Expected life of options (in years) 5 5
Schedule of Share-based Compensation, Activity [Table Text Block]	Weighted average grant date fair value For the six months ended June 30, 2015 2014 Stock options granted during the period $ 0.26 $ 0.16 Stock options vested during the period $ 0.18 $ 0.12 Stock options forfeited during the period $ 0.25 $ 0.44
Schedule of Nonvested Share Activity [Table Text Block]	Shares underlying stock options Weighted average grant date fair value Nonvested shares at January 1, 2015 275,000 $ 0.17 Nonvested shares at June 30, 2015 325,000 $ 0.22

Note 1 - Organization and Nat34

Note 1 - Organization and Nature of Operations (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Disclosure Text Block [Abstract]
Research and Development Expense	$ 1,355,783	$ 1,417,358

Note 2 - Summary of Significa35

Note 2 - Summary of Significant Accounting Policies (Details)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Dec. 31, 2014USD ($)	Jul. 10, 2009shares	Dec. 31, 2008shares
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	$ 21,926	$ (16,289)	$ (83,531)	$ (23,952)	$ (156,223)
Number of Reportable Segments			1
Allowance for Doubtful Accounts Receivable, Current	99,083		$ 99,083		186,085
Cash, Uninsured Amount		795,717		795,717
Revenues	4,834,899	$ 3,608,749	9,673,026	6,791,024
Deferred Revenue	8,563,929		8,563,929
Deferred Revenue, Current	$ 6,696,830		6,696,830		$ 5,840,875
Advertising Expense			406,502	228,530
Research and Development Expense			$ 1,355,783	1,417,358
Leasehold Improvements, Computers, Equipment and Furniture [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life			5 years
Software Development [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life			3 years
2009 Plan [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares) | shares						7,500,000
Stock Incentive Plan 1998 [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares) | shares							12,500,000
Customer Concentration Risk [Member] | Customer 1 [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Revenues			$ 1,249,000	$ 856,000
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage			13.00%	13.00%	15.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer 1 [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage			13.00%	13.00%
Minimum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Term of Software License			3 years
Derivative, Term of Contract			1 month
Maximum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Term of Software License			5 years
Derivative, Term of Contract			5 years 292 days

Note 2 - Summary of Significa36

Note 2 - Summary of Significant Accounting Policies (Details) - Revenue by Business Activity - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue activity
Revenue	$ 4,834,899	$ 3,608,749	$ 9,673,026	$ 6,791,024
Set-up Fees [Member]
Revenue activity
Revenue	1,617,609	1,136,021	2,882,153	1,943,854
Change Orders [Member]
Revenue activity
Revenue	212,767	83,866	354,808	196,954
Maintenance [Member]
Revenue activity
Revenue	1,269,530	1,052,015	2,501,407	2,011,646
Software Licenses [Member]
Revenue activity
Revenue	786,437	618,830	1,527,374	1,286,147
Professional Services [Member]
Revenue activity
Revenue	707,970	508,298	1,924,967	952,805
Hosting [Member]
Revenue activity
Revenue	$ 240,586	$ 209,719	$ 482,317	$ 399,618

Note 2 - Summary of Significa37

Note 2 - Summary of Significant Accounting Policies (Details) - Allowance for Doubtful Account Summary - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Allowance for Doubtful Account Summary [Abstract]
Beginning of period			$ 186,085	$ 65,341	$ 65,341
Bad debt expense	$ 14,972	$ 55,648	(5,402)	$ 76,002	147,543
Write-offs			(81,600)		(26,875)
Exchange rate impact			0		76
End of period	$ 99,083		$ 99,083		$ 186,085

Note 2 - Summary of Significa38

Note 2 - Summary of Significant Accounting Policies (Details) - Customer Concentration - Customer Concentration Risk [Member]	6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Sales Revenue, Net [Member]
Concentration Risk [Line Items]
Number of Customers	1	1	1
Percentage of Concentration Risk	13.00%	13.00%	15.00%
Accounts Receivable [Member]
Concentration Risk [Line Items]
Number of Customers	2	2	1
Percentage of Concentration Risk	31.00%	32.00%	18.00%

Note 2 - Summary of Significa39

Note 2 - Summary of Significant Accounting Policies (Details) - Revenue from European Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Note 2 - Summary of Significant Accounting Policies (Details) - Revenue from European Operations [Line Items]
	$ 4,834,899	$ 3,608,749	$ 9,673,026	$ 6,791,024
Sales Revenue, Net [Member] | Europe [Member]
Note 2 - Summary of Significant Accounting Policies (Details) - Revenue from European Operations [Line Items]
			11.00%	19.00%
Reportable Geographical Components [Member] | Europe [Member]
Note 2 - Summary of Significant Accounting Policies (Details) - Revenue from European Operations [Line Items]
			$ 1,084,178	$ 1,296,534

Note 4 - Earnings_(Loss) Per 40

Note 4 - Earnings/(Loss) Per Share (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Note 4 - Earnings/(Loss) Per Share (Details) [Line Items]
Weighted Average Number of Shares Outstanding, Basic	92,350,506	90,104,659	91,999,079	90,104,659
Common Stock, Shares, Outstanding	92,845,102		92,845,102		91,561,802
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			71,302,468	82,066,327
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit			$ 0.045
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit			0.50
Lower Range Limit [Member]
Note 4 - Earnings/(Loss) Per Share (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price	$ 0.25		0.25
Upper Range Limit [Member]
Note 4 - Earnings/(Loss) Per Share (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price	$ 0.50		0.50
Lower Range Limit [Member]
Note 4 - Earnings/(Loss) Per Share (Details) [Line Items]
Investment Warrants, Exercise Price			0.25
Upper Range Limit [Member]
Note 4 - Earnings/(Loss) Per Share (Details) [Line Items]
Investment Warrants, Exercise Price			$ 0.60
Restricted Stock [Member]
Note 4 - Earnings/(Loss) Per Share (Details) [Line Items]
Common Stock, Shares, Outstanding	2,866,681	850,007	2,866,681	850,007

Note 4 - Earnings_(Loss) Per 41

Note 4 - Earnings/(Loss) Per Share (Details) - Reconciliation of Anti-Dilutive Securities - shares	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Security	71,302,468	82,066,327
Shares Of Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Security	2,750,149	2,750,149
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Security	1,563,793	5,275,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Security	52,263,517	48,463,517
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Security	13,850,000	24,620,000
Shares Issuable For Accrued Interest [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-Dilutive Security	875,009	957,661

Note 4 - Earnings_(Loss) Per 42

Note 4 - Earnings/(Loss) Per Share (Details) - Computation of Diluted Earnings Per Share - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Computation of Diluted Earnings Per Share [Abstract]
Basic EPS	$ 4,627,529	$ 580,640	$ 1,821,485	$ (979,099)
Basic EPS	92,350,506	90,104,659	91,999,079	90,104,659
Basic EPS	$ 0.05	$ 0.01	$ 0.02	$ (0.01)
Effect of dilutive securities -	$ (1,460,161)	$ 0	$ (387,828)	$ 0
Effect of dilutive securities -	28,313,856	617,447	11,713,707	0
Effect of dilutive securities -	$ (0.05)	$ 0	$ (0.03)	$ 0
Diluted EPS	$ 3,167,368	$ 580,640	$ 1,433,657	$ (979,099)
Diluted EPS	120,664,362	90,722,106	103,712,786	90,104,659
Diluted EPS	$ 0.03	$ 0.01	$ 0.01	$ (0.01)

Note 5 - Property and Equipme43

Note 5 - Property and Equipment, Net (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Property, Plant and Equipment [Abstract]
Depreciation	$ 108,505	$ 122,433

Note 5 - Property and Equipme44

Note 5 - Property and Equipment, Net (Details) - Property and Equipment - USD ($)	12 Months Ended
	Dec. 31, 2014	Jun. 30, 2015
Property, Plant and Equipment [Line Items]
Cost	$ 3,666,692	$ 3,960,148
Accumulated Depreciation	3,198,556	3,305,811
Net Book Value	468,136	654,337
Computer And Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Cost	1,880,183	1,903,386
Accumulated Depreciation	1,482,737	1,546,029
Net Book Value	$ 397,446	357,357
Estimated Useful Lives	5 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Cost	$ 92,504	92,246
Accumulated Depreciation	82,353	84,796
Net Book Value	$ 10,151	7,450
Estimated Useful Lives	5 years
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Cost	$ 1,580,640	1,852,482
Accumulated Depreciation	1,528,418	1,569,680
Net Book Value	$ 52,222	282,802
Estimated Useful Lives	3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Cost	$ 113,365	112,034
Accumulated Depreciation	105,048	105,306
Net Book Value	$ 8,317	$ 6,728
Estimated Useful Lives	5 years

Note 6 - Intangible Assets, a45

Note 6 - Intangible Assets, at Cost (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Disclosure Text Block [Abstract]
Amortization of Intangible Assets	$ 10,057	$ 11,610	$ 20,237	$ 23,227

Note 6 - Intangible Assets, a46

Note 6 - Intangible Assets, at Cost (Details) - Intangible Assets - USD ($)	12 Months Ended
	Dec. 31, 2014	Jun. 30, 2015
Finite-Lived Intangible Assets [Line Items]
Cost	$ 1,646,603	$ 1,632,210
Accumulated Amortization	1,442,682	1,460,357
Net Book value	203,921	171,853
eClinical Customer List [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	1,392,701	1,392,701
Accumulated Amortization	1,392,701	1,392,701
Net Book value	$ 0	0
Estimated Useful Lives	3 years
Promasys B.V. Customer List [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	$ 120,305	110,742
Accumulated Amortization	9,357	12,305
Net Book value	$ 110,948	98,437
Estimated Useful Lives	15 years
Promasys B.V. Software Code [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	$ 72,837	72,837
Accumulated Amortization	16,995	24,279
Net Book value	$ 55,842	48,558
Estimated Useful Lives	5 years
Promasys B.V. URLs/Website [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	$ 60,760	55,930
Accumulated Amortization	23,629	31,072
Net Book value	$ 37,131	$ 24,858
Estimated Useful Lives	3 years

Note 6 - Intangible Assets, a47

Note 6 - Intangible Assets, at Cost (Details) - Intangible Assets, Future Amortization Expense	Jun. 30, 2015USD ($)
Intangible Assets, Future Amortization Expense [Abstract]
2,015	$ 20,297
2,016	37,486
2,017	21,950
2,018	19,522
2,019	7,383
Thereafter	65,215
Total	$ 171,853

Note 7 - Accounts Payable and48

Note 7 - Accounts Payable and Accrued Expenses (Details) - Accounts Payable and Accrued Expenses - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Accounts Payable and Accrued Expenses [Abstract]
Accounts payable	$ 823,291	$ 613,584
Accrued payroll and related costs	438,048	319,629
Other accrued expenses	79,159	85,248
Accrued interest	783,692	875,724
Total accounts payable and accrued expenses	$ 2,124,190	$ 1,894,185

Note 8 - Line of Credit and N49

Note 8 - Line of Credit and Notes Payable (Details) - USD ($)	Jan. 31, 2015	Jan. 01, 2014	Mar. 18, 2013	Jun. 30, 2015	Jun. 15, 2015	Apr. 01, 2015	Feb. 03, 2015	Dec. 31, 2014	Dec. 23, 2014	Dec. 01, 2014	Apr. 04, 2014	Dec. 18, 2013	Feb. 01, 2013
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 2,000,000				$ 5,000,000					$ 4,000,000
Debt Instrument, Interest Rate, Stated Percentage			2.00%
Debt Instrument, Periodic Payment, Interest			$ 9,500
Long-term Line of Credit				$ 5,000,000
Line of Credit Facility, Interest Rate at Period End				2.25%
Unsecured Debt				$ 7,731,500				$ 7,081,500
Notes Payable				$ 7,731,500				$ 7,081,500
Note Payable 4 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%				12.00%
Notes Payable				$ 980,000				$ 980,000
Note Payable 5 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%				12.00%
Notes Payable				$ 1,600,000				$ 1,600,000
Note Payable 6 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%				12.00%			12.00%
Debt Instrument, Face Amount											$ 45,000
Notes Payable				$ 45,000				$ 45,000
Note Payable 7 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%				12.00%			12.00%
Debt Instrument, Face Amount											$ 137,500
Notes Payable				$ 137,500				$ 137,500
Note Payable 8 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				10.00%				10.00%			10.00%
Debt Instrument, Face Amount											$ 120,000
Notes Payable				$ 120,000				$ 120,000
Debt Instrument, Repurchase Amount											3,424
Debt Instrument, Repurchased Face Amount											$ 123,424
Note Payable 9 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				10.00%				10.00%		10.00%
Debt Instrument, Face Amount										$ 300,000
Notes Payable				$ 300,000				$ 300,000
Debt Instrument, Repurchase Amount										8,562
Debt Instrument, Repurchased Face Amount										$ 308,562
Note Payable 10 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%				12.00%		12.00%
Debt Instrument, Face Amount										$ 90,000
Notes Payable				$ 90,000				$ 90,000
Note Payable 11 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%				12.00%		12.00%
Debt Instrument, Face Amount										$ 100,000
Notes Payable				$ 100,000				$ 100,000
Note Payable 12 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								12.00%					12.00%
Debt Instrument, Face Amount					$ 20,000								$ 20,000
Notes Payable								$ 20,000
Note Payable 13 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								12.00%	12.00%
Debt Instrument, Face Amount									$ 280,000
Notes Payable								$ 280,000
Note Payable 14 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%
Notes Payable				$ 2,860,000
Note Payable 15 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%
Notes Payable				$ 529,000
Note Payable 16 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				12.00%
Notes Payable				$ 950,000
Chief Executive Officer and Director Mr. Wit [Member] | Note Payable 14 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Repurchased Face Amount	$ 2,866,879
Chief Executive Officer and Director Mr. Wit [Member] | Note Payable 4 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		12.00%
Debt Instrument, Face Amount		$ 980,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)		3,920,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 0.25
Interest Payable		$ 980,000
Derivative Liability		628,086
Notes Payable		$ 351,914
Debt Instrument, Convertible, Remaining Discount Amortization Period		39 months
Chief Executive Officer and Director Mr. Wit [Member] | Note Payable 5 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage											12.00%
Debt Instrument, Face Amount											$ 1,600,000
Chief Executive Officer and Director Mr. Wit [Member] | Note Payable 14 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Instrument, Face Amount	$ 2,860,000
Debt Instrument, Repurchase Amount	$ 6,879
Chief Executive Officer and Director Mr. Wit [Member] | Note Payable 15 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Instrument, Face Amount	$ 529,000
Chief Executive Officer and Director Mr. Wit [Member] | Note Payable 16 [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Instrument, Face Amount	$ 950,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)	3,800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 0.25
Interest Payable	$ 670,000
Derivative Liability	868,127
Notes Payable	$ 81,873
Debt Instrument, Convertible, Remaining Discount Amortization Period	26 months
Debt Instrument, Repurchase Amount	$ 280,000
Chairman and Chief Technology Officer [Member]
Note 8 - Line of Credit and Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage						12.00%
Debt Instrument, Repurchase Amount						$ 20,000

Note 8 - Line of Credit and N50

Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Dec. 23, 2014	Dec. 01, 2014	Apr. 04, 2014	Mar. 18, 2013	Feb. 01, 2013
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Interest rate						2.00%
Ending principal	$ 7,731,500	$ 7,081,500
Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Discount on note payable	0	0
Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Discount on note payable	0	0
Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	792,500	812,500
Discount on note payable	0	0
Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	5,832,930	5,700,791
Discount on note payable	$ (1,106,070)	$ (568,209)
Note Payable 4 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017	Apr. 1, 2017
Interest rate	12.00%	12.00%
Ending principal	$ 980,000	$ 980,000
Note Payable 4 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 4 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 4 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 4 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 980,000	$ 980,000
Note Payable 5 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017	Apr. 1, 2017
Interest rate	12.00%	12.00%
Ending principal	$ 1,600,000	$ 1,600,000
Note Payable 5 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 5 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 5 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 5 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 1,600,000	$ 1,600,000
Note Payable 6 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017	Apr. 1, 2017
Interest rate	12.00%	12.00%			12.00%
Ending principal	$ 45,000	$ 45,000
Note Payable 6 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 6 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 6 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	45,000	45,000
Note Payable 6 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 0	$ 0
Note Payable 7 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017	Apr. 1, 2017
Interest rate	12.00%	12.00%			12.00%
Ending principal	$ 137,500	$ 137,500
Note Payable 7 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 7 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 7 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	137,500	137,500
Note Payable 7 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 0	$ 0
Note Payable 8 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017	Apr. 1, 2017
Interest rate	10.00%	10.00%			10.00%
Ending principal	$ 120,000	$ 120,000
Note Payable 8 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 8 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 8 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	120,000	120,000
Note Payable 8 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 0	$ 0
Note Payable 9 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017	Apr. 1, 2017
Interest rate	10.00%	10.00%		10.00%
Ending principal	$ 300,000	$ 300,000
Note Payable 9 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 9 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 9 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	300,000	300,000
Note Payable 9 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 0	$ 0
Note Payable 10 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017	Apr. 1, 2017
Interest rate	12.00%	12.00%		12.00%
Ending principal	$ 90,000	$ 90,000
Note Payable 10 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 10 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 10 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	90,000	90,000
Note Payable 10 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 0	$ 0
Note Payable 11 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017	Apr. 1, 2017
Interest rate	12.00%	12.00%		12.00%
Ending principal	$ 100,000	$ 100,000
Note Payable 11 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 11 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0	0
Note Payable 11 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	100,000	100,000
Note Payable 11 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 0	$ 0
Note Payable 14 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017
Interest rate	12.00%
Ending principal	$ 2,860,000
Note Payable 14 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 14 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 14 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 14 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 2,860,000
Note Payable 15 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017
Interest rate	12.00%
Ending principal	$ 529,000
Note Payable 15 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 15 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 15 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 15 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 529,000
Note Payable 16 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2017
Interest rate	12.00%
Ending principal	$ 950,000
Note Payable 16 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 16 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 16 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note Payable 16 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 950,000
Note payable 17 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date	Apr. 1, 2018
Interest rate	12.00%
Ending principal	$ 20,000
Note payable 17 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note payable 17 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note payable 17 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	0
Note payable 17 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal	$ 20,000
Note Payable 1 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date		Jan. 1, 2016
Interest rate		12.00%
Ending principal		$ 529,000
Note Payable 1 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 1 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 1 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 1 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		$ 529,000
Note Payable 2 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date		Jan. 1, 2016
Interest rate		12.00%
Ending principal		$ 20,000
Note Payable 2 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 2 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 2 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 2 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		$ 20,000
Note Payable 3 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date		Mar. 31, 2016
Interest rate		12.00%
Ending principal		$ 2,860,000
Note Payable 3 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 3 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 3 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 3 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		$ 2,860,000
Note Payable 12 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date		Jan. 1, 2016
Interest rate		12.00%					12.00%
Ending principal		$ 20,000
Note Payable 12 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 12 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 12 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		20,000
Note Payable 12 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		$ 0
Note Payable 13 [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Maturity date		Apr. 1, 2017
Interest rate		12.00%	12.00%
Ending principal		$ 280,000
Note Payable 13 [Member] | Short-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 13 [Member] | Short-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 13 [Member] | Long-term Debt [Member] | Non-Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		0
Note Payable 13 [Member] | Long-term Debt [Member] | Related Party [Member]
Note 8 - Line of Credit and Notes Payable (Details) - Notes Payable [Line Items]
Ending principal		$ 280,000

Note 9 - Convertible Notes Pa51

Note 9 - Convertible Notes Payable (Details) - USD ($)

May. 01, 2015

Mar. 30, 2011

Dec. 16, 2008

Aug. 29, 2008

Jun. 30, 2015

Dec. 31, 1999

May. 07, 2015

Apr. 30, 2015

Apr. 27, 2015

Apr. 01, 2015

Jan. 31, 2015

Dec. 31, 2014

Jul. 31, 2014

Apr. 28, 2014

Apr. 21, 2014

Dec. 09, 2013

Dec. 05, 2013

Mar. 18, 2013

Mar. 12, 2013

Mar. 06, 2013

Feb. 27, 2013

Feb. 22, 2013

Jun. 30, 2011

Dec. 31, 2009

Sep. 30, 2009

Aug. 31, 2008

Jun. 30, 2008

Feb. 29, 2008

Jun. 30, 2004

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

2.00%

Convertible Notes Payable

$ 9,660,000

Convertible Notes 10% [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Convertible Notes Payable

$ 862,500

Debt Issuance Cost

119,625

Proceeds from Issuance of Debt

$ 742,875

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 1.25

Debt Conversion, Converted Instrument, Amount

$ 787,500

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

1,495,179

Long-term Debt, Gross

$ 75,000

Interest Payable

120,968

Secured Convertible Debenture [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Notes Payable

$ 1,400,000

Repayments of Notes Payable

$ 200,000

Secured Convertible Debenture [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

1,200,000

Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Notes Payable

$ 5,075,000

$ 2,270,000

$ 1,490,000

Convertible Debentures [Member] | Non-Related Party [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 160,000

Chief Executive Officer and Director Mr. Wit [Member] | Secured Convertible Debenture [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 1,100,000

$ 1,100,000

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.25

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

5,600,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 0.25

Chief Executive Officer and Director Mr. Wit [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.25

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

5,960,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 0.25

Lenders [Member] | Secured Convertible Debenture [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Lenders [Member] | Secured Convertible Debenture [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 100,000

1,200,000

Lenders [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

12.00%

Convertible Notes Payable

1,440,000

Lenders [Member] | Convertible Debentures [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

100,000

$ 200,000

$ 50,000

$ 100,000

$ 200,000

$ 100,000

$ 200,000

4,505,000

$ 1,490,000

Lenders [Member] | Convertible Debentures [Member] | Extended Maturity Debentures 2 [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

1,490,000

Chief Officer, Mr. Wit and Mr. van Kesteren [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.50

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

4,540,000

Mr. van Kesteren and Mr. Wit [Member] | Convertible Debentures [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 150,000

150,000

$ 1,920,000

Director Mr. van Kesteren [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

10.00%

Director Mr. van Kesteren [Member] | Convertible Debentures [Member] | Non-Related Party [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 150,000

Director Mr. van Kesteren [Member] | Convertible Debentures [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 160,000

$ 150,000

$ 150,000

$ 160,000

Director Mr. Wit [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Convertible Notes Payable

$ 1,260,000

$ 4,475,000

4,475,000

4,350,000

$ 510,000

$ 4,200,000

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.50

$ 0.50

Debt Conversion, Converted Instrument, Amount

$ 4,350,000

$ 510,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

8,700,000

3,540,000

Director Mr. Wit [Member] | Convertible Debentures [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

1,770,000

1,770,000

1,770,000

Director Mr. Wit [Member] | Convertible Debentures [Member] | Extended Maturity Debentures 1 [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

4,475,000

Director Mr. Wit [Member] | Convertible Debentures [Member] | Extended Maturity Debentures 2 [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 1,440,000

Chief Executive Officer, Director, Chief Operating Officer, Chairman, Chief Technology Officer, Chief Financial Officer and Directors [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 0.50

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

10,150,000

Officers, Directors and Affiliate [Member] | Convertible Debentures [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 4,980,000

Chief Executive Officer [Member] | Chief Executive Officer and Director Mr. Wit [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

4,475,000

Chief Operating Officer [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

25,000

Chairman and Chief Technology Officer [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Chairman and Chief Technology Officer [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Convertible Notes Payable

$ 5,000

Related Party Transaction, Amounts of Transaction

$ 5,000

Former Director [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Former Director [Member] | Convertible Debentures [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 15,000

$ 15,000

President [Member] | Convertible Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

President [Member] | Convertible Debentures [Member] | Extended Maturity Debentures [Member]

Note 9 - Convertible Notes Payable (Details) [Line Items]

Convertible Notes Payable

$ 25,000

Note 9 - Convertible Notes Pa52

Note 9 - Convertible Notes Payable (Details) - Convertible Debt - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Mar. 18, 2013
Debt Instrument [Line Items]
Interest Rate			2.00%
Principal & Carry Amount at Period End	$ 9,660,000
Short Term Related	75,000	$ 75,000
Short Term Non Related	75,000	75,000
Long Term Related	775,000	775,000
Long Term Non Related	$ 775,000	$ 775,000
Convertible Note Payable 10% $862,500 [Member]
Debt Instrument [Line Items]
Maturity Date	Jun. 30, 2004
Interest Rate	10.00%
Original Principal	$ 862,500
Principal & Carry Amount at Period End	75,000
Allocated Discount	0
Amortized Discount	0
Discount at Period End	0
Convertible Note Payable 10% $862,500 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	0
Long Term Non Related	0
Convertible Note Payable 10% $862,500 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	75,000
Short Term Non Related	75,000
Long Term Related	0
Long Term Non Related	$ 0
Convertible Notes Payable 10% $150,000 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2017	Apr. 1, 2016
Interest Rate	10.00%	10.00%
Original Principal	$ 150,000	$ 150,000
Principal & Carry Amount at Period End	150,000	150,000
Allocated Discount	135,600	135,600
Amortized Discount	135,600	135,600
Discount at Period End	0	0
Convertible Notes Payable 10% $150,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	0	0
Long Term Non Related	0	0
Convertible Notes Payable 10% $150,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	150,000	150,000
Long Term Non Related	$ 150,000	$ 150,000
Convertible Notes Payable 10% $2,120,000 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2017	Jan. 1, 2016
Interest Rate	10.00%	10.00%
Original Principal	$ 2,120,000	$ 2,120,000
Principal & Carry Amount at Period End	1,770,000	1,770,000
Allocated Discount	1,916,480	1,916,480
Amortized Discount	1,916,480	1,916,480
Discount at Period End	0	0
Convertible Notes Payable 10% $2,120,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	1,770,000	1,770,000
Long Term Non Related	1,770,000	1,770,000
Convertible Notes Payable 10% $2,120,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	0	0
Long Term Non Related	$ 0	$ 0
Convertible Notes Payable 12 Percent 260,000 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2017
Interest Rate	12.00%
Original Principal	$ 260,000
Principal & Carry Amount at Period End	260,000
Allocated Discount	70,200
Amortized Discount	70,200
Discount at Period End	0
Convertible Notes Payable 12 Percent 260,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	0
Long Term Non Related	0
Convertible Notes Payable 12 Percent 260,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	260,000
Long Term Non Related	$ 260,000
Convertible Notes Payable, 12%, $4,570,000 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2017
Interest Rate	12.00%
Original Principal	$ 4,570,000
Principal & Carry Amount at Period End	4,475,000
Allocated Discount	1,233,900
Amortized Discount	1,233,900
Discount at Period End	0
Convertible Notes Payable, 12%, $4,570,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	4,475,000
Long Term Non Related	4,475,000
Convertible Notes Payable, 12%, $4,570,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	0
Long Term Non Related	$ 0
Convertible Notes Payable, 12%, $215,000 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2018
Interest Rate	12.00%
Original Principal	$ 215,000
Principal & Carry Amount at Period End	215,000
Allocated Discount	58,050
Amortized Discount	58,050
Discount at Period End	0
Convertible Notes Payable, 12%, $215,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	0
Long Term Non Related	0
Convertible Notes Payable, 12%, $215,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	215,000
Long Term Non Related	$ 215,000
Convertible Notes Payable, 12%, $25,000 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2018
Interest Rate	12.00%
Original Principal	$ 25,000
Principal & Carry Amount at Period End	25,000
Allocated Discount	6,750
Amortized Discount	6,750
Discount at Period End	0
Convertible Notes Payable, 12%, $25,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	25,000
Long Term Non Related	25,000
Convertible Notes Payable, 12%, $25,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	0
Long Term Non Related	$ 0
Convertible Notes Payable 12% 1,300,000 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2017	Jan. 1, 2016
Interest Rate	12.00%	12.00%
Original Principal	$ 1,300,000	$ 1,300,000
Principal & Carry Amount at Period End	1,100,000	1,100,000
Allocated Discount	488,800	488,800
Amortized Discount	488,800	488,800
Discount at Period End	0	0
Convertible Notes Payable 12% 1,300,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	1,100,000	1,100,000
Long Term Non Related	1,100,000	1,100,000
Convertible Notes Payable 12% 1,300,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	0	0
Long Term Non Related	$ 0	$ 0
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2018
Interest Rate	12.00%
Original Principal	$ 100,000
Principal & Carry Amount at Period End	100,000
Allocated Discount	37,600
Amortized Discount	37,600
Discount at Period End	0
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	0
Long Term Non Related	0
Convertible Notes Payable, 12%, $100,000 issued 9/30/2009, Second Issuance [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	100,000
Long Term Non Related	$ 100,000
Convertible Notes Payable, 12%, $1,440,000 issued 12/31/2009 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2017
Interest Rate	12.00%
Original Principal	$ 1,440,000
Principal & Carry Amount at Period End	1,440,000
Allocated Discount	904,320
Amortized Discount	904,320
Discount at Period End	0
Convertible Notes Payable, 12%, $1,440,000 issued 12/31/2009 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	1,440,000
Long Term Non Related	1,440,000
Convertible Notes Payable, 12%, $1,440,000 issued 12/31/2009 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0
Short Term Non Related	0
Long Term Related	0
Long Term Non Related	$ 0
Convertible Notes Payable 12% $50,000 [Member]
Debt Instrument [Line Items]
Maturity Date	Apr. 1, 2018	Jan. 1, 2016
Interest Rate	12.00%	12.00%
Original Principal	$ 50,000	$ 50,000
Principal & Carry Amount at Period End	50,000	50,000
Allocated Discount	31,400	31,400
Amortized Discount	31,400	31,400
Discount at Period End	0	0
Convertible Notes Payable 12% $50,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	0	0
Long Term Non Related	0	0
Convertible Notes Payable 12% $50,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	50,000	50,000
Long Term Non Related	50,000	50,000
Total [Member]
Debt Instrument [Line Items]
Original Principal	11,092,500	11,097,500
Principal & Carry Amount at Period End	9,660,000	9,665,000
Allocated Discount	4,883,100	4,884,450
Amortized Discount	4,883,100	4,884,450
Discount at Period End	0	0
Total [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	0	0
Short Term Non Related	0	0
Long Term Related	8,810,000	8,815,000
Long Term Non Related	8,810,000	8,815,000
Total [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related	75,000	75,000
Short Term Non Related	75,000	75,000
Long Term Related	775,000	775,000
Long Term Non Related	$ 775,000	$ 775,000
Convertible Notes Payable 10% $862,500 [Member]
Debt Instrument [Line Items]
Maturity Date		Jun. 30, 2004
Interest Rate		10.00%
Original Principal		$ 862,500
Principal & Carry Amount at Period End		75,000
Allocated Discount		0
Amortized Discount		0
Discount at Period End		0
Convertible Notes Payable 10% $862,500 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		0
Long Term Non Related		0
Convertible Notes Payable 10% $862,500 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		75,000
Short Term Non Related		75,000
Long Term Related		0
Long Term Non Related		$ 0
Convertible Notes Payable, 12%, $375,000 [Member]
Debt Instrument [Line Items]
Maturity Date		Jan. 1, 2016
Interest Rate		12.00%
Original Principal		$ 375,000
Principal & Carry Amount at Period End		375,000
Allocated Discount		101,250
Amortized Discount		101,250
Discount at Period End		0
Convertible Notes Payable, 12%, $375,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		0
Long Term Non Related		0
Convertible Notes Payable, 12%, $375,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		375,000
Long Term Non Related		$ 375,000
Convertible Notes Payable 12% $4,600,000 [Member]
Debt Instrument [Line Items]
Maturity Date		Jan. 1, 2016
Interest Rate		12.00%
Original Principal		$ 4,600,000
Principal & Carry Amount at Period End		4,505,000
Allocated Discount		1,242,000
Amortized Discount		1,242,000
Discount at Period End		0
Convertible Notes Payable 12% $4,600,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		4,505,000
Long Term Non Related		4,505,000
Convertible Notes Payable 12% $4,600,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		0
Long Term Non Related		$ 0
Convertible Note Payable 12% $100,000 Issued on 12/16/2008 [Member]
Debt Instrument [Line Items]
Maturity Date		Apr. 1, 2016
Interest Rate		12.00%
Original Principal		$ 100,000
Principal & Carry Amount at Period End		100,000
Allocated Discount		27,000
Amortized Discount		27,000
Discount at Period End		0
Convertible Note Payable 12% $100,000 Issued on 12/16/2008 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		0
Long Term Non Related		0
Convertible Note Payable 12% $100,000 Issued on 12/16/2008 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		100,000
Long Term Non Related		$ 100,000
Convertible Notes Payable 12% $100,000 Issued 09/30/2009 [Member]
Debt Instrument [Line Items]
Maturity Date		Jan. 1, 2016
Interest Rate		12.00%
Original Principal		$ 100,000
Principal & Carry Amount at Period End		100,000
Allocated Discount		37,600
Amortized Discount		37,600
Discount at Period End		0
Convertible Notes Payable 12% $100,000 Issued 09/30/2009 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		0
Long Term Non Related		0
Convertible Notes Payable 12% $100,000 Issued 09/30/2009 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		100,000
Long Term Non Related		$ 100,000
Convertible Notes Payable 12% $1,400,000 [Member]
Debt Instrument [Line Items]
Maturity Date		Jan. 1, 2016
Interest Rate		12.00%
Original Principal		$ 1,440,000
Principal & Carry Amount at Period End		1,440,000
Allocated Discount		904,320
Amortized Discount		904,320
Discount at Period End		0
Convertible Notes Payable 12% $1,400,000 [Member] | Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		1,440,000
Long Term Non Related		1,440,000
Convertible Notes Payable 12% $1,400,000 [Member] | Non-Related Party [Member]
Debt Instrument [Line Items]
Short Term Related		0
Short Term Non Related		0
Long Term Related		0
Long Term Non Related		$ 0

Note 9 - Convertible Notes Pa53

Note 9 - Convertible Notes Payable (Details) - Convertible Debt Maturity Payments	Jun. 30, 2015USD ($)
Note 9 - Convertible Notes Payable (Details) - Convertible Debt Maturity Payments [Line Items]
Total	$ 9,660,000
Convertible Debt [Member]
Note 9 - Convertible Notes Payable (Details) - Convertible Debt Maturity Payments [Line Items]
2,015	75,000
2,016	0
2,017	9,195,000
2,018	$ 390,000

Note 10 - Fair Value Measurem54

Note 10 - Fair Value Measurement (Details) - 6 months ended Jun. 30, 2015 - USD ($)	Total
Note 10 - Fair Value Measurement (Details) [Line Items]
Goodwill, Translation Adjustments (in Dollars)	$ 47,427
Minimum [Member]
Note 10 - Fair Value Measurement (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years
Maximum [Member]
Note 10 - Fair Value Measurement (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	15 years

Note 10 - Fair Value Measurem55

Note 10 - Fair Value Measurement (Details) - Fair Value of Liabilities Measured on a Recurring Basis - USD ($)		Jun. 30, 2015	[2]	Dec. 31, 2014
Derivatives: (1) (2)
Derivative liability fair value	[1]	$ 6,434,792		$ 9,639,462	[3]
Conversion Feature Liability [Member]
Derivatives: (1) (2)
Derivative liability fair value	[1]	1,954,155		2,944,402	[3]
Warrant Liability [Member]
Derivatives: (1) (2)
Derivative liability fair value	[1]	4,480,637		6,695,060	[3]
Fair Value, Inputs, Level 1 [Member]
Derivatives: (1) (2)
Derivative liability fair value	[1]	0		0	[3]
Fair Value, Inputs, Level 1 [Member] | Conversion Feature Liability [Member]
Derivatives: (1) (2)
Derivative liability fair value		0	[1]	0
Fair Value, Inputs, Level 1 [Member] | Warrant Liability [Member]
Derivatives: (1) (2)
Derivative liability fair value	[1]	0		0	[3]
Fair Value, Inputs, Level 2 [Member]
Derivatives: (1) (2)
Derivative liability fair value	[1]	0		0	[3]
Fair Value, Inputs, Level 2 [Member] | Conversion Feature Liability [Member]
Derivatives: (1) (2)
Derivative liability fair value		0	[1]	0
Fair Value, Inputs, Level 2 [Member] | Warrant Liability [Member]
Derivatives: (1) (2)
Derivative liability fair value	[1]	0		0	[3]
Fair Value, Inputs, Level 3 [Member]
Derivatives: (1) (2)
Derivative liability fair value	[1]	6,434,792		9,639,462	[3]
Fair Value, Inputs, Level 3 [Member] | Conversion Feature Liability [Member]
Derivatives: (1) (2)
Derivative liability fair value		1,954,155	[1]	2,944,402
Fair Value, Inputs, Level 3 [Member] | Warrant Liability [Member]
Derivatives: (1) (2)
Derivative liability fair value	[1]	$ 4,480,637		$ 6,695,060	[3]
[1]	The fair value at the measurement date is equal to their carrying value on the balance sheet
[2]	The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with thefollowing assumptions for the six month period ended June 30, 2015
[3]	The fair value of the derivative instruments was estimated using the Income Approach and the Black Scholes option pricing model with thefollowing assumptions for the year ended December 31, 2014

Note 10 - Fair Value Measurem56

Note 10 - Fair Value Measurement (Details) - Fair Value Assumptions	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk free interest rate	0.24%	0.13%
Dividend yield	0.00%	0.00%
Minimum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Expected volatility	73.80%	119.80%
Minimum [Member] | Conversion Feature Liability [Member]
Expected life (range in years)
Conversion feature liability	1 year 277 days	1 year
Minimum [Member] | Warrant Liability [Member]
Expected life (range in years)
Conversion feature liability	186 days	1 year
Maximum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Expected volatility	144.00%	155.70%
Maximum [Member] | Conversion Feature Liability [Member]
Expected life (range in years)
Conversion feature liability	2 years 277 days	1 year 3 months
Maximum [Member] | Warrant Liability [Member]
Expected life (range in years)
Conversion feature liability	2 years 277 days	2 years 3 months

Note 10 - Fair Value Measurem57

Note 10 - Fair Value Measurement (Details) - Fair Value of Assets Aquired on Non-recurring Basis - Fair Value, Measurements, Nonrecurring [Member] - USD ($)		Jun. 30, 2015	Dec. 31, 2014
Acquired assets (3)
Promasys B.V. customer list (4)	[1],[2]	$ 98,437	$ 110,948
Promasys B.V. software code (4)	[1],[2]	48,558	55,842
Promasys B.V. URLs/website (4)	[1],[2]	24,858	37,131
Total	[2]	171,853	$ 203,921
Fair Value, Inputs, Level 1 [Member]
Acquired assets (3)
Promasys B.V. customer list (4)	[1],[2]	0
Promasys B.V. software code (4)	[1],[2]	0
Promasys B.V. URLs/website (4)	[1],[2]	0
Total	[2]	0
Fair Value, Inputs, Level 2 [Member]
Acquired assets (3)
Promasys B.V. customer list (4)	[1],[2]	0
Promasys B.V. software code (4)	[1],[2]	0
Promasys B.V. URLs/website (4)	[1],[2]	0
Total	[2]	0
Fair Value, Inputs, Level 3 [Member]
Acquired assets (3)
Promasys B.V. customer list (4)	[1],[2]	136,253
Promasys B.V. software code (4)	[1],[2]	72,943
Promasys B.V. URLs/website (4)	[1],[2]	68,814
Total	[2]	$ 278,010
[1]	The acquired Promasys B.V. software code, customer list and URLs/website are not measured on a recurring basis since their initial fair value has been deemed to have a finite life and is being amortized periodically. Instead the Company performs an impairment analysis on a quarterly basis in order to determine whether the carrying value of the assets reflects the fair value of the assets in a market based transaction.
[2]	The fair value of the acquired assets was estimated using the Income Approach with a discounted cash flow valuation methodology applied.

Note 10 - Fair Value Measurem58

Note 10 - Fair Value Measurement (Details) - Fair Value of Goodwill - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Goodwill [Line Items]
Goodwill	$ 549,193	$ 596,620
Fair Value, Inputs, Level 3 [Member] | Promasys B.V. [Member]
Goodwill [Line Items]
Goodwill	$ 549,193	$ 596,620

Note 10 - Fair Value Measurem59

Note 10 - Fair Value Measurement (Details) - Unrealized Gain or Loss Included in Earnings - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Unrealized Gain or Loss Included in Earnings [Abstract]
The net amount of gains for the period included in earnings attributable to the unrealized gain from changes in derivative liabilities at the reporting date	$ 4,072,798	$ 2,802,571
Total unrealized gains included in earnings	$ 4,072,798	$ 2,802,571

Note 10 - Fair Value Measurem60

Note 10 - Fair Value Measurement (Details) - Change in Level 3 Financial Liabilities Fair Value - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Derivatives:
Balance, beginning of year	$ (9,639,462)	$ (9,070,183)
Net realized gains/(losses)	0	0
Net Unrealized (gains)/losses relating to instruments still held at the reporting date	4,072,798	58,807
Net purchases, issuances and settlements	(868,128)	(628,086)
Net transfers in and/or out of Level 3	0	0
Balance, end of period	(6,434,792)	(9,639,462)
Conversion Feature Liability [Member]
Derivatives:
Balance, beginning of year	(2,944,402)	(3,126,206)
Net realized gains/(losses)	0	0
Net Unrealized (gains)/losses relating to instruments still held at the reporting date	990,247	181,804
Net purchases, issuances and settlements	0	0
Net transfers in and/or out of Level 3	0	0
Balance, end of period	(1,954,155)	(2,944,402)
Warrant Liability [Member]
Derivatives:
Balance, beginning of year	(6,695,060)	(5,943,977)
Net realized gains/(losses)	0	0
Net Unrealized (gains)/losses relating to instruments still held at the reporting date	3,082,551	(122,997)
Net purchases, issuances and settlements	(868,128)	(628,086)
Net transfers in and/or out of Level 3	0	0
Balance, end of period	$ (4,480,637)	$ (6,695,060)

Note 11 - Commitments and Con61

Note 11 - Commitments and Contingencies (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
Operating Leases, Rent Expense	$ 482,711	$ 443,987
Patent Royalty Percentage Obligation	2.00%
Other Expenses	$ 64,822	$ 82,684

Note 11 - Commitments and Con62

Note 11 - Commitments and Contingencies (Details) - Minimum Royalty Payments Per Year	Jun. 30, 2015USD ($)
Minimum Royalty Payments Per Year [Abstract]
2,015	$ 360,296
2,016	504,222
2,017	317,516
2,018	244,026
2,019	246,450
Thereafter	715,775
Total	$ 2,388,285

Note 11 - Commitments and Con63

Note 11 - Commitments and Contingencies (Details) - Future Minimum Lease Payments	Jun. 30, 2015USD ($)
Future Minimum Lease Payments [Abstract]
2,015	$ 337,500
2,016	450,000
2,017	450,000
Total	$ 1,237,500

Note 12 - Related Party Trans64

Note 12 - Related Party Transactions (Details)	May. 01, 2015USD ($)	Feb. 03, 2015USD ($)	Jan. 31, 2015USD ($)$ / sharesshares	Oct. 05, 2011USD ($)	May. 13, 2011USD ($)	Apr. 13, 2010USD ($)	Dec. 31, 2014USD ($)	Nov. 23, 2011USD ($)	Oct. 31, 2011USD ($)	Oct. 28, 2011USD ($)	Sep. 30, 2011USD ($)	Dec. 31, 2010USD ($)	Sep. 30, 2010USD ($)	Jun. 29, 2010USD ($)	Sep. 30, 2009USD ($)$ / shares	Dec. 16, 2008USD ($)$ / sharesshares	Aug. 29, 2008USD ($)$ / sharesshares	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Dec. 31, 2011USD ($)$ / sharesshares	Apr. 01, 2015	Jan. 01, 2015USD ($)	Dec. 23, 2014USD ($)	Jul. 31, 2014USD ($)	Apr. 21, 2014USD ($)	Jan. 01, 2014USD ($)$ / sharesshares	Dec. 18, 2013USD ($)	Dec. 05, 2013USD ($)	Mar. 18, 2013USD ($)	Feb. 22, 2013USD ($)	Jan. 01, 2013USD ($)$ / sharesshares	Oct. 16, 2012USD ($)shares	Mar. 31, 2011USD ($)$ / sharesshares	Dec. 31, 2009USD ($)shares	Aug. 31, 2008	Jun. 30, 2008USD ($)	Feb. 29, 2008USD ($)
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																															2.00%
Convertible Notes Payable																		$ 9,660,000		$ 9,660,000
Line of Credit Facility, Maximum Borrowing Capacity		$ 5,000,000																											$ 4,000,000		$ 2,000,000
Long-term Line of Credit																		$ 5,000,000		$ 5,000,000
Line of Credit Facility, Interest Rate at Period End																		2.25%		2.25%
Interest Expense, Related Party																		$ 672,649	$ 573,558	$ 1,299,785	$ 1,240,176
Chairman and Chief Technology Officer [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																							12.00%
The Northern Trust Company [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 5,000,000																											$ 4,000,000		$ 2,000,000
Line of Credit Facility, Interest Rate During Period		2.00%
Long-term Line of Credit																		$ 5,000,000		$ 5,000,000
Line of Credit Facility, Interest Rate at Period End																		2.25%		2.25%
Notes Payable, Other Payables [Member] | Director Mr. Wit [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			12.00%																			12.00%			12.00%			12.00%					12.00%		12.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | shares			3,800,000																			6,400,000						3,920,000					2,116,000		11,467,517
Notes Payable, Related Parties			$ 950,000																			$ 1,600,000			$ 280,000			$ 980,000					$ 529,000		$ 2,866,879
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ / shares			$ 0.25																			$ 0.25						$ 0.25					$ 0.25		$ 0.25
Debt Conversion, Original Debt, Amount				$ 130,000	$ 96,000	$ 450,000		$ 60,000	$ 82,000	$ 123,000	$ 342,000		$ 695,000	$ 115,000								$ 767,000
Notes Payable, Other Payables [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Convertible Notes Payable			$ 2,860,000
Debt Instrument, Increase (Decrease), Net							$ (6,879)
Convertible Debentures [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																																				12.00%
Convertible Notes Payable																$ 5,075,000	$ 2,270,000																			$ 1,490,000
Convertible Debentures [Member] | Chairman and Chief Technology Officer [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Related Party Transaction, Amounts of Transaction	$ 5,000
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Convertible Notes Payable																																$ 5,000
Convertible Debentures [Member] | Director Mr. van Kesteren [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12.00%																																				10.00%
Convertible Debentures [Member] | Director Mr. van Kesteren [Member] | Extended Maturity Debentures [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Convertible Notes Payable	$ 160,000																	$ 150,000		$ 150,000							$ 150,000			$ 160,000
Convertible Debentures [Member] | Director Mr. Wit [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																	10.00%
Convertible Notes Payable			4,475,000												$ 4,350,000		$ 1,260,000															4,475,000						$ 510,000	$ 4,200,000
Due to Related Parties																		$ 15,704,000		$ 15,704,000
Debt Conversion, Converted Instrument, Amount																$ 4,350,000	$ 510,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | shares																8,700,000	3,540,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ / shares																$ 0.50	$ 0.50
Notes Payable, Related Parties																																							$ 150,000
Debt Conversion, Converted Instrument, Rate																12.00%
Convertible Debentures [Member] | Director Mr. Wit [Member] | Extended Maturity Debentures [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Convertible Notes Payable			1,770,000												$ 1,770,000																	$ 1,770,000
Convertible Debentures [Member] | Director Mr. Wit [Member] | Purchased From Chief Financial Officer [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Convertible Notes Payable																																		$ 125,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | shares																																		250,000
Convertible Debentures [Member] | Director Mr. Wit [Member] | Subsequent Event [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Convertible Notes Payable																								$ 1,770,000
Convertible Debentures [Member] | Non-Related Party [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Convertible Notes Payable																										$ 160,000
Convertible Debentures [Member] | Non-Related Party [Member] | Director Mr. van Kesteren [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Convertible Notes Payable																										$ 150,000
Aggregated Convertible Debt July - September 30, 2009 [Member] | Director Mr. Wit [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage															12.00%
Convertible Notes Payable			1,100,000												$ 1,100,000
Debt Instrument, Convertible, Number of Equity Instruments															4,400,000
Warrants and Rights Outstanding															$ 4,400,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ / shares															$ 0.25
Aggregated Convertible Debt October -December 31, 2009 [Member] | Director Mr. Wit [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																																				12.00%
Convertible Notes Payable			1,440,000																																	$ 1,440,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | shares																																				5,760,000
First Issuance [Member] | Notes Payable, Other Payables [Member] | Director Mr. Wit [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount												$ 1,197,500
Second Issuance [Member] | Notes Payable, Other Payables [Member] | Director Mr. Wit [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount												$ 409,379
Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Director Mr. Wit [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Extinguishment of Debt, Amount			280,000
Accrued Interest [Member] | Notes Payable, Other Payables [Member] | Director Mr. Wit [Member]
Note 12 - Related Party Transactions (Details) [Line Items]
Extinguishment of Debt, Amount			$ 670,000

Note 13 - Stockholders' (Defi65

Note 13 - Stockholders' (Deficit) (Details) - USD ($)	Jun. 30, 2015	Jun. 15, 2015	Jun. 11, 2015	Mar. 31, 2015	Mar. 20, 2015	Oct. 31, 2014	Jul. 31, 2014	Jun. 11, 2014	Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Common Stock, Shares Authorized	250,000,000								250,000,000	250,000,000
Preferred Stock, Shares Authorized	10,000,000								10,000,000	10,000,000
Common Stock, Shares, Issued	92,845,102								92,845,102	91,561,802
Common Stock, Shares, Outstanding	92,845,102								92,845,102	91,561,802
Class of Warrant or Right, Outstanding	52,263,517								52,263,517	48,463,517		44,728,873
Convertible Debt (in Dollars)	$ 9,660,000								$ 9,660,000
Convertible Common Stock, Shares Reserved for Futre Issuance	24,610,000								24,610,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period									282,500	150,000
Series A Preferred Stock [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized	5,000,000								5,000,000	5,000,000
Preferred Stock, Dividend Rate, Percentage									5.00%
Preferred Stock, Shares Issued	4,125,224								4,125,224	4,125,224
Preferred Stock, Shares Outstanding	4,125,224								4,125,224	4,125,224
Series B Preferred Stock [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized	230,000								230,000	230,000
Preferred Stock, Shares Issued	0								0	0
Preferred Stock, Shares Outstanding	0								0	0
Series C Preferred Stock [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized	747,500								747,500	747,500
Preferred Stock, Shares Issued	0								0	0
Preferred Stock, Shares Outstanding	0								0	0
Series D Preferred Stock [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Preferred Stock, Shares Authorized	250,000								250,000	250,000
Preferred Stock, Shares Issued	250,000								250,000	250,000
Preferred Stock, Shares Outstanding	250,000								250,000	250,000
Restricted Stock [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Common Stock, Shares, Outstanding	2,866,681								2,866,681		850,007
Restricted Stock [Member] | Senior Management And Board Of Directors [Member] | Equity Incentive Plan 2009 [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross							1,400,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period							3 years
Restricted Stock [Member] | Senior Management Team [Member] | Equity Incentive Plan 2009 [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross					665,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					3 years
Restricted Stock [Member] | Board of Directors Chairman [Member] | Equity Incentive Plan 2009 [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross								360,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period								3 years
Employee Stock Option [Member] | Former Director [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period						57,143
Employee Stock Option [Member] | Former Employee [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	20,000			7,500
Employee Stock Option [Member] | Employee [Member]
Note 13 - Stockholders' (Deficit) (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		225,000	5,800

Note 13 - Stockholders' (Defi66

Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends [Line Items]
Preferred Stock, Dividend, Cumulative Arrearage	$ 4,770,964	$ 4,564,702
Series A Preferred Stock [Member]
Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends [Line Items]
Preferred Stock, Dividend, Cumulative Arrearage	$ 2,688,984	$ 2,482,722
Preferred Stock, Dividend, Cumulative Arrearage Per Share (in Dollars per share)	$ 0.65	$ 0.60
Series B Preferred Stock [Member]
Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends [Line Items]
Preferred Stock, Dividend, Cumulative Arrearage	$ 609,887	$ 609,887
Preferred Stock, Dividend, Cumulative Arrearage Per Share (in Dollars per share)	$ 3.05	$ 3.05
Series C Preferred Stock [Member]
Note 13 - Stockholders' (Deficit) (Details) - Cumulative Arrearage of Undeclared Dividends [Line Items]
Preferred Stock, Dividend, Cumulative Arrearage	$ 1,472,093	$ 1,472,093
Preferred Stock, Dividend, Cumulative Arrearage Per Share (in Dollars per share)	$ 4.37	$ 4.37

Note 13 - Stockholders' (Defi67

Note 13 - Stockholders' (Deficit) (Details) - Dividends Payable - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Series A Preferred Stock [Member]
Dividends Payable [Line Items]
Dividends accreted	$ 102,283	$ 102,283
Divideds accreted per share	$ 0.025	$ 0.025
Series B Preferred Stock [Member]
Dividends Payable [Line Items]
Dividends accreted	$ 0	$ 0
Divideds accreted per share	$ 0	$ 0
Series C Preferred Stock [Member]
Dividends Payable [Line Items]
Dividends accreted	$ 0	$ 0
Divideds accreted per share	$ 0	$ 0

Note 13 - Stockholders' (Defi68

Note 13 - Stockholders' (Deficit) (Details) - Warrants - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Class of Warrant or Right [Line Items]
Number outstanding (in Shares)	52,263,517	48,463,517	44,728,873
Weighted average	1 year 284 days	1 year 62 days
Weighted average exercise price	$ 0.34	$ 0.35
Number exercisable (in Shares)	52,263,517	48,463,517
Weighed average exercise price	$ 0.34	$ 0.35
Minimum [Member]
Class of Warrant or Right [Line Items]
Range of exercise price	0.25	0.25
Maximum [Member]
Class of Warrant or Right [Line Items]
Range of exercise price	$ 0.60	$ 0.60

Note 13 - Stockholders' (Defi69

Note 13 - Stockholders' (Deficit) (Details) - Warrants Activity - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Warrants Activity [Abstract]
Balance at December 31,	52,263,517	48,463,517	44,728,873
Warrants exercisable at June 30, 2015	52,263,517	48,463,517
Weighted average fair value of warrants granted (in Dollars)	$ 0.10	$ 0.10
Issued (in Dollars)	$ 3,800,000	$ 3,920,000
Exercised	0	0
Expired/forfeited	0	(185,356)

Note 13 - Stockholders' (Defi70

Note 13 - Stockholders' (Deficit) (Details) - Accumulated Other Comprehensive Gain (Loss) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Accumulated Other Comprehensive Gain (Loss) [Abstract]
Foreign Currency Translation			$ (243,827)	$ (87,604)	$ (87,604)
Foreign currency translation adjustment			(243,827)	(87,604)	(87,604)
Foreign currency translation adjustment	$ 21,926	$ (16,289)	(83,531)	(23,952)	(156,223)
Accumulated other comprehensive income (loss)	21,926	$ (16,289)	(83,531)	$ (23,952)	(156,223)
Foreign Currency Translation	(327,358)		(327,358)		(243,827)
Foreign currency translation adjustment	$ (327,358)		$ (327,358)		$ (243,827)

Note 14 - Employee Equity Inc71

Note 14 - Employee Equity Incentive Plans (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2008
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	2,517,500		3,130,000	5,745,000
Proceeds from Stock Options Exercised (in Dollars)	$ 27,250	$ 0
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense (in Dollars)	$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$ 0.26	$ 0.16
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars)	$ 51,910
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 146 days
Equity Incentive Plan 2009 [Member]
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	7,500,000
Stock Option Expiration Term	5 years
Vesting Percentage Year 1	50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	2,517,500
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	3,650,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	931,057
Stock Incentive Plan 1998 [Member]
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized					12,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number					450,000
Maximum [Member] | Equity Incentive Plan 2009 [Member]
Note 14 - Employee Equity Incentive Plans (Details) [Line Items]
Stock Option Grant Term	10 years

Note 14 - Employee Equity Inc72

Note 14 - Employee Equity Incentive Plans (Details) - Stock Option Activity - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Stock Option Activity [Abstract]
Number of shares	2,517,500	3,130,000	5,745,000
Weighted average exercise price (per share)	$ 0.21	$ 0.20	$ 0.29
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	1 year 215 days	1 year 215 days	1 year 255 days
Aggregate intrinsic value	$ 125,800	$ 364,900	$ 93,945
Vested and exercisable at June 30, 2015	2,192,500
Vested and exercisable at June 30, 2015	$ 0.21
Vested and exercisable at June 30, 2015	1 year 73 days
Vested and exercisable at June 30, 2015	$ 120,750
Number of shares	175,000	150,000
Weighted average exercise price (per share)	$ 0.27	$ 0.16
Number of shares	(282,500)	(150,000)
Weighted average exercise price (per share)	$ 0.12	$ 0.13
Number of shares	(505,000)	(2,615,000)
Weighted average exercise price (per share)	$ 0.25	$ 0.40

Note 14 - Employee Equity Inc73

Note 14 - Employee Equity Incentive Plans (Details) - Vested Shares - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Vested Shares [Abstract]
Number of options vested	125,000	433,334
Fair value of options vested	$ 22,235	$ 50,845

Note 14 - Employee Equity Inc74

Note 14 - Employee Equity Incentive Plans (Details) - Stock Options Oustanding - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Low Price range	$ 0.045
High Price range	0.50
Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Low Price range	0	$ 0
High Price range	$ 0.20	$ 0.20
Outstanding stock options (in Shares)	1,792,500	2,080,000
Weighted average remaining contractual life-outstanding	1 year 208 days	1 year 357 days
Weighted average outstanding strike price-outstanding	$ 0.13	$ 0.13
Vested stock options (in Shares)	1,642,500	1,855,000
Weighted average remaining contractual life-vested	1 year 135 days	1 year 262 days
Weighted average outstanding strike price-vested	$ 0.13	$ 0.12
Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Low Price range	0.21	0.21
High Price range	$ 0.29	$ 0.29
Outstanding stock options (in Shares)	175,000	600,000
Weighted average remaining contractual life-outstanding	3 years 9 months	335 days
Weighted average outstanding strike price-outstanding	$ 0.22	$ 0.24
Vested stock options (in Shares)	100,000	550,000
Weighted average remaining contractual life-vested	2 years 354 days	251 days
Weighted average outstanding strike price-vested	$ 0.21	$ 0.25
Range Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Low Price range	0.30	0.30
High Price range	$ 0.49	$ 0.49
Outstanding stock options (in Shares)	100,000	0
Weighted average remaining contractual life-outstanding	4 years 248 days
Weighted average outstanding strike price-outstanding	$ 0.30	$ 0
Vested stock options (in Shares)	0	0
Weighted average remaining contractual life-vested
Weighted average outstanding strike price-vested	$ 0	$ 0
Range Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Low Price range	0.50	0.50
High Price range	$ 0.70	$ 0.70
Outstanding stock options (in Shares)	450,000	450,000
Weighted average remaining contractual life-outstanding	65 days	248 days
Weighted average outstanding strike price-outstanding	$ 0.50	$ 0.50
Vested stock options (in Shares)	450,000	450,000
Weighted average remaining contractual life-vested	65 days	248 days
Weighted average outstanding strike price-vested	$ 0.50	$ 0.50
Range Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Low Price range	0	0
High Price range	$ 0.70	$ 0.70
Outstanding stock options (in Shares)	2,517,500	3,130,000
Weighted average remaining contractual life-outstanding	1 year 215 days	1 year 215 days
Weighted average outstanding strike price-outstanding	$ 0.21	$ 0.20
Vested stock options (in Shares)	2,192,500	2,855,000
Weighted average remaining contractual life-vested	1 year 73 days	1 year 127 days
Weighted average outstanding strike price-vested	$ 0.21	$ 0.21

Note 14 - Employee Equity Inc75

Note 14 - Employee Equity Incentive Plans (Details) - Fair Value Assumptions of Share-Based Payments	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Fair Value Assumptions of Share-Based Payments [Abstract]
Risk-free interest rate	0.98%	0.93%
Expected dividend yield	0.00%	0.00%
Expected volatility	192.20%	199.00%
Expected life of options (in years)	5 years	5 years

Note 14 - Employee Equity Inc76

Note 14 - Employee Equity Incentive Plans (Details) - Weighted Average Grant Date Fair Value Activity - $ / shares	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Weighted Average Grant Date Fair Value Activity [Abstract]
Stock options granted during the period	$ 0.26	$ 0.16
Stock options vested during the period	0.18	0.12
Stock options forfeited during the period	$ 0.25	$ 0.44

Note 14 - Employee Equity Inc77

Note 14 - Employee Equity Incentive Plans (Details) - Status of Non-Vested Shares - Jun. 30, 2015 - $ / shares	Total
Status of Non-Vested Shares [Abstract]
Nonvested shares at January 1, 2015	275,000
Nonvested shares at January 1, 2015	$ 0.17
Nonvested shares at June 30, 2015	325,000
Nonvested shares at June 30, 2015	$ 0.22